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1 Introduction 
1.1 Organisation of the skin 
The skin epithelium forms the largest organ of the body and has crucial barrier 
functions. It protects the body from dehydration and environmental assaults (such as 
pathogens, UV radiation and mechanical stress). In addition, the skin plays a key role 
in thermoregulation and sensory perception (Segre, 2006). Mammalian skin is a 
complex organised and multilayered tissue consisting of an epidermis, a dermis and 
a subcutaneous layer (hypodermis) (Fig 1A). The epidermis is a stratified epithelium 
comprising the interfollicular epidermis (IFE) and associated hair follicles (HF) and 
sebaceous glands (SG). The underlying mensenchymal connective tissue (dermis) 
supplies the epidermis with nutrients and stimulates proliferation. The subcutis is 
comprised of adipocytes and serves as a nutrient storage for the epidermis and 
dermis (cutis). Furthermore, it connects the cutis with underlying tissues (e.g. muscle) 
(Alberts, 2002; Montagna and Parakkal, 1974). 
 
 
Fig1: Organisation of the skin 
(A) H/E stained section of the skin showing the epidermis, dermis (DE) and the subcutis. The 
epidermis consists of an IFE and associated HF and SG (Niemann and Watt, 2002).  
(B) Scheme depicting different layers of the interfollicular epidermis (Fuchs and Nowak, 
2008). 
 
Introduction 
 2 
1.2 The epidermis 
The epidermis forms the outermost layer of the skin and is directly exposed to 
various environmental assaults. Therefore, a highly compartmentalised and multi-
layered epithelium has been evolved. 
1.2.1 The interfollicular epidermis (IFE) 
Murine IFE is composed of 4 cell layers: the stratum basale, stratum spinosum, 
stratum granulosum and stratum corneum (Fig 1B). Epidermal homeostasis underlies 
a strict spatial control of proliferation and differentiation. Proliferating keratinocytes 
are confined to a single basal layer, stratum basale, which is attached to the 
basement membrane (BM). A reciprocal exchange of signals with the underlying 
mesenchyme (dermis) is required to induce proliferation of the epidermis (Watt and 
Hogan, 2000). Keratinocytes destined to differentiate detach from the underlying BM 
and leave the basal layer. Major structural changes at basal to spinous layer 
transition are accompained by a switch in keratin expression, from Keratin (K) 
K14/K5 (Nelson and Sun, 1983) in basal layer to K1/K10 suprabasally (Fuchs and 
Green, 1980). Differentiating keratinocytes traverse the distinct epidermal layers, 
before finally shedding from the epidermal surface as flattened cornified cells. In 
murine epidermis, the outermost layer, stratum corneum, is arranged in stacks of 
large hexagonal cells with deposited lipids which are essential for barrier acquisition  
(Blanpain and Fuchs, 2009; Fuchs and Nowak, 2008; Jones et al., 2007). 
1.2.2 The hair follicle (HF) 
Similar to the IFE, differentiation and proliferation of the HF are confined to distinct 
compartments. Proliferating keratinocytes are found in the outer root sheath (ORS), 
the secondary hair germ (HG) and the hair bulb (at the base of the HF). Terminal 
differentiation is restricted to the concentric inner layers including the inner root 
sheath (IRS) and the hair shaft (HS). Basically, the HF is partitioned in a permanent 
and a cycling portion, resulting in an accessory temporal control of HF renewal (Fig 
2A) (Hardy, 1992; Niemann and Watt, 2002).  
Introduction 
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Fig 2: Structure of the pilosebaceous unit 
(A) The pilosebaceous unit is formed by HF and its attached SG. HF have a permanent and 
a cycling portion. The permanent part contains the HFSC niche (bulge, B),the secondary hair 
germ (HG) (B; Jaks et al., 2008) the upper isthmus (UI) and SG, whereas the lower cycling 
portion produces new hair including all the different lineages of the HS and IRS (C; 
Cotsarelis, 2006).  
 
During HF growth period, cell type specification of rapidly dividing TA-matrix cells is 
executed at the basis of the HF, called bulb. This process involves 7 terminal 
differentiation programs including 3 cell lineages for the HS and 4 for the IRS (Fig 
2C) (Cotsarelis, 2006; Krause and Foitzik, 2006; Rogers, 2004; Schneider et al., 
2009) The IRS rigidly supports and guides the HS during maturation. Layers of HS 
and IRS extrude their organelles and are composed of tightly packed bundles 
assembled by keratin filaments supporting tensile strengths of the hair fibres. The HG 
and the bulb region are located in close proximity to a cluster of cells called dermal 
papillae (DP) (Fig 2B). DP cells provide signals to stimulate hair growths during 
morphogenesis and normal development (Rendl et al., 2005).  
In addition to the cyclic part the HF also encompasses a permanent portion including 
the HFSC niche (bulge), the upper isthmus (UI), the junctional zone (JZ) and the 
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opening of the hair channel being connected to the IFE, called infundibulum (INF) 
(Blanpain and Fuchs, 2009; Cotsarelis, 2006). 
1.2.3 The sebaceous gland (SG)  
Functional SG are important for barrier acquisition and protection against pathogens 
and environmental assaults (Schneider and Paus, 2009; Thody and Shuster, 1989). 
During late embryonic morphogenesis of the HF, SG develop as outgrowths of the 
ORS between the infundibulum and the UI. Fully developed SG has been classified 
into three distinct regions, the peripheral, the maturation and the necrosis zone (Fig 
3). At the peripheral basal layer, small undifferentiated and mitotically active cells 
assure maintenance of the gland. Upon maturation, sebocytes accumulate lipid 
droplets and are displaced towards the centre of the gland (necrosis zone). Finally, 
cells disintegrate and lipid containing sebum is lubricated into the hair channel. The 
sebaceous duct (SD) directly connects the uni- or multilobular organised SG to the 
hair channel thereby facilitating the holocrine secretion of the sebum (Zouboulis et 
al., 2008b).  
   
Fig 3: Structure of the SG 
SG consists of 3 different zones: The growth is comprised of proliferating cells. Upon 
differentiation basal cells migrate towards the maturation zone (MZ). They accumulate lipids 
and are displaced into the centre (necrosis zone). Finally, these cells burst and sebum is 
released into the hair channel (Schneider and Paus, 2009). 
 
Differentiated sebocytes are characterised by SCD1 (steaoryl-coenzyme A 
desaturase1) (Binczek et al., 2007; Ntambi, 1995; Sampath et al., 2009; Zheng et al., 
1999), MC5R (Melanocortin5 receptor) and PPARγ (peroxisome proliferator activator 
Introduction 
 5 
receptor γ-expression (Zhang et al., 2006). Lipid droplets of fully maturated cells can 
be visualised by the use of lipid dyes (OilRedO, NileRed). Notably, several 
malfunctions have been associated with deregulated sebaceous differentiation 
including Acne vulgaris and sebaceous tumourigenesis (Zouboulis, 2004). 
 The existence of multiple compartments within the epidermis indicates that a 
complex organised signalling network is required to control regeneration of each 
integral part of the epidermis. 
1.3 Epidermal homeostasis 
Mammalian epidermis is regenerated constantly throughout the entire life. This 
continuous replacement of damaged or dead cells guarantees homeostasis of the 
epidermal tissue. Indeed, epidermal homeostasis is a highly dynamic process, which 
is maintained by multiple stem (SC) and progenitor cell populations (Blanpain and 
Fuchs, 2006; Jaks et al., 2008; Jaks et al., 2010).  
1.3.1 SC characteristics and identification 
SC are defined as a population of long-lived multipotent cells that have been 
associated with infrequent cell cycling. Upon stimuli from the surrounding 
microenvironment (SC niche), SC become mobilised and are activated to divide. It is 
thought that one of the two daughter cells is utilised to replenish the SC pool. The 2nd 
daughter called transit amplifying (TA) cell undergoes distinct rounds of replications 
and is destined to a particular cell lineage (Fuchs and Segre, 2000). Several studies 
have taken advantage of the slow cycling nature of the SC (Bickenbach et al., 1986; 
Cotsarelis et al., 1990; Morris and Potten, 1994; Potten et al., 1974). They have 
administered the nucleotide analogon 3H-thymidine or BrdU for a prolonged period to 
assure uptake in all tissue cells capable to divide. Following a certain chasing time, 
replicating cells dilute the label, whereas cells with an infrequent cell cycle retain the 
3H-thymidine or BrdU.  
1.3.2 Assays to test SC identity 
The proliferative potential and differentiation capacity of epidermal SC populations 
can also be tested in vitro (colony forming assay). Therefore, growth and morphology 
of a certain number of seeded cells is monitored over a period of 2-4 weeks. 
Multicompetent SC give rise to large colonies (holoclones), whereas TA cells 
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generate colonies of moderate size (meroclones). Cultivation of more differentiated 
cells leads to the formation of small abortive clones (paraclones) (Barrandon and 
Green, 1985, 1987; Jones and Watt, 1993; Morris and Potten, 1994). In addition, SC 
identity can be assayed by skin reconstitution assays (e.g. graft chamber assay). 
Transplantation multipotent epidermal SC into nude mice lead to a regeneration of 
the entire epidermis including IFE, SG and HF (Blanpain et al., 2004).  
 Until now, several distinct SC and progenitor population and marker molecules 
have been identified for almost each integral part of the epidermis (see Table 1), 
provoking the question if the different SC compartments are somehow 
interconnected.  
1.3.3 Epidermal SC compartments  
1.3.3.1 SC in the IFE 
Previously, it has been shown that the IFE has its own SC reservoir (reviewed in 
(Jones and Simons, 2008)). Indeed, LRC have been found in the IFE (Braun et al., 
2003; Lavker and Sun, 1983) and human keratinocytes derived from the IFE 
exhibiting high β1-integrin levels have a high proliferative potential in vitro (Jones et 
al., 1995; Jones and Watt, 1993).  
1.3.3.2 SC of the HF bulge 
The best characterised compartment of HFSC is the HF bulge (Fig 4), which belongs 
to the permanent portion of the HF and is most likely established after morpho-
genesis of the HF (Nowak et al., 2008). HFSC divide infrequently as demonstrated by 
label retention approaches (Cotsarelis et al., 1990; Lavker et al., 2003). This pulse-
chase concept was adapted to a tetracycline-inducible, GFP-tagged Histone-2B 
version and has not only confirmed the slow cycling nature of bulge cells. The fact 
that some cells retained the label over months indicates that they subsisted in a more 
quiescent state or were not actively involved in hair regeneration. These data imply 
that bulge cells represent a more heterogeneous population with regard to their 
proliferative features (Sotiropoulou et al., 2008; Tumbar et al., 2004; Waghmare et 
al., 2008). SC identity of HF bulge cells has been assessed by in vitro studies and 
clonal analysis of bulge-derived progeny (Table 1). Indeed, several potential HFSC 
bulge marker have been described including Keratin 15 (K15), CD34, Tcf3 (T-cell 
factor3), NFATc1 (Nuclear factor of activated T-cells, cytoplasmic1), Lhx2 
Introduction 
 7 
(LIM/homeobox protein2) and Sox9 (SRY box9) (Liu et al., 2003; Lyle et al., 1998; 
Merrill et al., 2001; Nguyen et al., 2006; Nowak et al., 2008; Rhee et al., 2006; 
Trempus et al., 2003; Vidal et al., 2005). 
HFSC from the bulge region have been purified based on CD34+/Itga6high-
expression. Transplantation of these isolated bulge cells resulted in reconstitution of 
all epidermal lineages including HF, SG, and IFE (Blanpain et al., 2004). The 
contribution of bulge cells to HF regeneration has been well documented by a series 
of lineage tracing experiments in vivo (Table 1). Genetic targeting of the entire HF 
bulge by a K15 regulatory sequence revealed that K15+ve cell populations were 
competent to regenerate the entire hair follicle (Morris et al., 2004). A more distinct 
cell population located at the lower tip of the HF bulge giving rise to the HG was 
monitored for either Lgr5 (leucine-rich repeat-containing G-protein coupled receptor) 
expression (Jaks et al., 2008) or by analysing label retention (Greco et al., Zhang et 
al., Legue et al., 2010).  
 
Fig 4: The HFSC niche and its markers 
The HF bulge region (B) is the best characterised SC niche and positive for K15, LRC, CD34, 
Lhx2, Tcf3, NFATc1, Sox9, Lgr5 and Itga6high signal. Lineage tracing experiments were 
performed with the molecules highlighted in bold.  
1.3.3.3 SC/progenitor reservoirs of the isthmus 
The upper istmus, a region between the bulge and the SG, was identified to comprise 
CD34 negative, K15 negative, ScaI negative SC/progenitor cells which are 
clonogenic in culture (Fig 5, Jensen et al., 2008). The UI is recognised by the MTS24 
antibody (mouse thymic stroma24, Nijhof et al., 2006). The corresponding epitope for 
MTS24, Plet1 (glycoylphosphatidylinositol-anchored glycoprotein1) (Depreter et al., 
2008), has recently been identified and is also expressed in more differentiated 
keratinocytes of the hair lineages (Raymond et al., 2010). Residing in the more 
central isthmus, genetically labelled Lgr6+ve cells have recently been traced towards 
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the IFE and the SG. Interestingly, Lgr6+ve keratinocytes do not express the molecular 
signature of bulge SC and only partially overlap with other epidermal SC/progenitor 
marker (MTS24/Plet1 or Lrig1) (Snippert et al., 2010).  
Fig 5: Epidermal SC/ progenitor niches of the UI and JZ 
The UI (green) contains progenitors which are MTS24/Plet1 and Lgr6+ve. The JZ (blue) and 
the periphery of the SG is characterised by Lrig1 expression. Blimp1 seems to mark 
unipotent progenitors at the junction of SG and HF. Lineage tracing experiments were 
performed with the molecules highlighted in bold. 
 
1.3.4 Bipotent progenitors at the JZ 
The region of the JZ is comprised of bipotent Lrig1+ve cell population that seem to 
contribute to both, SG and IFE renewal (Fig 5 and Jensen et al., 2009). 
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Table 1: Identification of several marker molecules at different epidermal 
SC/progenitor compartments 
Niche marker proof of SC identitiy potency regulation reference 
    lineage tracing 
Transplan- 
tation 
clonogenic  
in vitro       
entire 
bulge 
K15 x x x multi-potent 
VitDR, β-
catenin 
Liu et al., 
2003; 
Morris et 
al., 2004 
LRC x x x multi potent   
Cotsarelis 
et al., 
1990; 
Tumbar et 
al., 2004 
CD34   x x multi-potent   
Trempus 
et al., 
2003; 
Blanpain 
et al., 
2004 
Lhx2           Rhee et al., 2006 
Tcf3         Wnt Nguyen et al., 2006 
NFATc1         BMP Horsley et al., 2008 
lower 
bulge Lgr5 x x x 
multi-
potent Wnt 
Jaks et 
al., 2008 
central 
isthmus Lgr6 x x   
bi- 
potent  
Snippert 
et al., 
2010 
upper 
isthmus 
MTS24/ 
Plet1     x     
Nijhof et 
al., 2006; 
Jensen et 
al., 2008 ; 
Depreter 
et al., 
2008, 
Raymond 
et al., 
2010 
junctional 
zone Lrig1   x x 
bi- 
potent 
EGFR?c-
myc 
Jensen et 
al., 2009 
SG Blimp1 x   x uni- potent c-myc 
Horsley et 
al., 2006 
IFE LRC x   x     
(Ghazizad
eh and 
Taichman
, 2001) 
  
The discovery of diverse SC/progenitor populations in the epidermis (summarised in 
Table1) raises important questions: What is the functional significance of the different 
progenitor pools within the epidermis? What are the underlying signalling networks 
maintaining and controlling these different compartments? 
Introduction 
 10 
1.3.5 Epidermal regeneration 
1.3.5.1 Regeneration of the IFE 
Different models have been postulated how the IFE is regenerated. Originally, it was 
hypothesised the IFE is organised into columns termed epidermal proliferative units 
(EPU) consisting of about 10 basal cells comprised of a single central SC (LRC) 
surrounded by TA cells and differentiating columnar stacks of cells extending from 
the stratum basale to the stratum granulosum (Mackenzie and Bickenbach, 1985; 
Potten, 1974). 
In contrast, it has recently been postulated that a single cell population which neither 
shares SC nor TA cell characteristics contributes to the homeostasis of the IFE 
(Clayton et al., 2007; Doupe et al., 2010; Jones and Simons, 2008). Instead, resident 
and more committed progenitors (CP) give rise to the IFE.  
1.3.5.2 Cyclic regeneration of the HF  
Murine HFs undergo a cyclic regeneration and renew within a time frame of about 4 
weeks (Fig 6). Since the first and the second postnatal hair cycles are synchronised, 
the HF represents an excellent system to study the regulation of SC activation and 
quiescence during skin homeostasis. HF regeneration is separated into distinct 
phases of resting (telogen), activation (telogen to anagen transition), growth (anagen) 
and regression (catagen) (Lavker and Sun, 1983; Lavker et al., 2003; Millar, 2002; 
Muller-Rover et al., 2001). During telogen, HFSC of the bulge are in quiescent state. 
Upon mesenchymal stimuli sent from the DP (Driskell et al., 2009; Enshell-Seijffers et 
al., 2010; Rendl et al., 2008), HFSC are activated and more primed SC from the HG 
are mobilised. This two-step mechanism involves proliferation and migration of more 
activated SC from the HG along the ORS towards a newly forming hair matrix to 
support hair growth (anagen phase), before activated bulge SC replenish lost HG 
cells (Greco et al., 2009; Jaks et al., 2008; Legue et al., 2010; Zhang et al., 2009). 
The new HF forms adjacent to the old (club) hair that eventually will be shed (Milner 
et al., 2002). Anagen is followed by catagen, where the lower cycling part of the HF is 
regressed, mainly by apoptosis. Additionally, HS differentiation terminates 
concomitant with club hair formation thereby preparing the DP and the permanent 
part of the HF for the next telogen (Alonso and Fuchs, 2006; Cotsarelis, 2006). 
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Fig 6: Cyclic renewal of the HF 
Upon mesenchymal stimuli (telogen to anagen transition), HFSC resing in the bulge (B) and 
HG are mobilised to promote hair growth (anagen). Activated SC from the HG migrate and 
generate proliferating TA cells located in the hair matrix which eventually result in the 
terminally differentiated HS to generate a new hair. Activated HFSC replenish the lost HG 
cells. During catagen phase, the lower part of the HF regresses and the HF enters the resting 
phase (telogen). 
 
To date, it has been well documented that SC from the HF bulge are involved in 
cyclic HF regeneration. So far, it is not absolutely clear, whether HFSC can also 
contribute to other epidermal compartments like the IFE or the SG during skin 
homeostasis.  
1.3.5.3 Homeostasis of the SG 
The high turn-over of the SG requires a constant renewal of cells, suggesting SC or 
progenitor cells to be involved in SG homeostasis. The source of the SC regenerating 
the SG still remains to be identified.  
(1) Currently, two hypotheses exist how the SG are regenerated on a cellular level: 
Stem cells or progenitors from different epidermal compartments are mobilised and 
contribute to SG homeostasis (Blanpain et al., 2004; Jensen et al., 2009; Panteleyev 
et al., 2000; Snippert et al., 2010; Taylor et al., 2000). 
(2) Unipotent progenitors residing at the periphery of the SG are committed to 
sebaceous lineage. Initial long-term retroviral-mediated clonal analyses revealed that 
a noticeable number of exclusively labelled SG persisted, albeit other compartments 
such as the HF or the IFE remained negative This observation suggested that the SG 
comprises a resident SC population (Ghazizadeh and Taichman, 2001). Recent 
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studies indicate that unipotent progenitors are located at the junction of the SG and 
the HF and are characterised by the expression of Blimp1 (B lymphocyte induced 
maturation protein-1). Fate mapping analyses suggest that Blimp1+ve progenitors are 
capable to maintain the SG (Horsley et al., 2006). In contrast, in human skin or 
tumour samples Blimp1 marks more matured sebocytes (Sellheyer and Krahl, 2009). 
However, a remaining issue to be investigated is: what is the origin of cells giving rise 
to unipotent Blimp1+ve progenitors?  
Ablation of Blimp1 leads to SG hyperplasia and an increased proliferation in the HF 
bulge indicating that HFSC respond to this signals if homeostasis is disturbed 
(Horsley et al., 2006). 
 Furthermore, it has been well documented that upon wounding, SC/progenitor 
populations from the hair matrix, the HF bulge, the central isthmus or the JZ are 
recruited to the injured tissue, indicating a tremendous plasticity of epidermal SC to 
ensure rapid repair of the damaged tissue (Ito et al., 2005; Ito et al., 2007; Langton et 
al., 2008; Levy et al., 2005; Levy et al., 2007). This also implies that a fast response 
of the underlying signalling networks is required to mobilise and direct these 
SC/progenitor populations towards the site of primary injury.  
1.4 Regulation of epidermal regeneration  
A complex network consisting of various signalling cascades has been evolved to 
control epidermal morphogenesis and homeostasis. Several lines of experiments 
have provided evidence that gradients of Wnt and BMP signalling are essential for 
controlling SC quiescence, activation and cell type specification by HFSC (DasGupta 
et al., 2002; Kobielak et al., 2007; Li and Clevers, 2010; Lo Celso et al., 2004; Millar, 
2002).  
1.4.1 Wnt/β-catenin signalling 
 
In the absence of a Wnt signal, β-catenin is phosphorylated and targeted for 
proteasomal degradation by a destruction complex consisting of CK1, GSK3β, Apc 
and Axin among other proteins (Fig 7). Upon binding of Wnt to its receptor Frizzled 
and its co-receptor LRP5/6, Dishevelled binds to Frizzled and recruits the destruction 
complex to the membrane through interactions with Axin. Cytoplasmatic β-catenin is 
now stabilized, accumulates and translocates to the nucleus and binds to TCF/LEF1 
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transcription factors thereby displacing a complex repressing transcription (Groucho 
and CBP). Expression of target genes including cell cycle regulators (CyclinD1), 
adhesion molecules (E-Cadherin) is induced but also a feedback loop of components 
of Wnt-pathway including Wnt-inhibitors (Nusse, 2005). 
 
Fig 7: Scheme depicting the Wnt/β-catenin pathway in repressed (left) and active state 
(right) (Fodde and Brabletz, 2007) 
 
Consistent with the observation in other epithelial systems, such as the intestine 
(Barker et al., 2010; Barker et al., 2007; Sato et al., 2009), quiescence of HFSC is 
achieved by the secretion of Wnt-inhibitory signals by the mesenchyme (DP). 
Simultaneously, during refractory stage of telogen, the DP promotes the BMP 
pathway; thereby activating NFATc1 (nuclear factor of activated T cells c1). NFATc1 
represses CDK4 (cyclin dependent kinase 4) and stimulates the expression of cell 
cycle inhibitors. The mirror image is observed in the SC activation phase. The HFSC 
niche deciphers BMP inhibitory signals from the DP which in turn leads to the 
inactivation of NFATc1 followed by cell cycle progression (Horsley et al., 2008). 
Additionally, Wnt-signalling is induced thereby promoting SC activation and HF 
growth. Once a bulge SC becomes activated, the expression of downstream effectors 
such as Sonic hedgehog (Shh) is induced to control proliferation and differentiation at 
the basis of the HF (Chiang et al., 1999; St-Jacques et al., 1998). The fate decision of 
matrix cells is dependent on Wnt-mediated Lef1 (lymphoid enhancer factor1) 
signalling determining lineage commitment towards HS differentiation (Merrill et al., 
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2001), whereas BMP signalling stimulates expression of GATA3 thereby inducing 
differentiation into the IRS (Kobielak et al., 2003) 
In addition to the Wnt and BMP pathways, an important function for Hedgehog, c-myc 
and Notch signalling during epidermal regeneration has been reported (Blanpain et 
al., 2006; Estrach et al., 2008; Niemann et al., 2003; St-Jacques et al., 1998; Watt et 
al., 2008; Watt and Jensen, 2009).  
 A deregulation of these signalling networks has major implications for 
epidermal homeostasis and cancer.  
1.4.2 Impaired Wnt/β-Catenin signalling results in a disturbed 
tissue homeostasis  
Previously, it has been shown that the manipulation of the Wnt/β-catenin pathway 
causes perturbations of the epidermal differentiation programme (Fig 8).  
Overexpressing an active mutant of β-catenin in vivo leads to an unscheduled de 
novo formation of hair follicles (Gat et al., 1998; Lo Celso et al., 2004; Lowry et al., 
2005).  
 
Fig 8: Manipulation of canonical Wnt signalling affects epidermal homeostasis.  
Overexpression of active β-catenin (red) determines fate decision towards the hair lineages, 
whereas repression (blue) promotes differentiation cell type specification of keratinocytes 
towards lineages of the SG and IFE. SG and IFE specification can also be stimulated by the 
expression of ΔNLef1. Over-expression of Hh and c-myc also stimulates sebaceous 
commitment.  
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Impairment of signalling by Lef1, which together with β-catenin is crucial for 
appropriate HF development, promotes sebaceous fate and squamous differentiation 
(Merril et al, 2001; Niemann et al., 2002).  
Recently, it has been demonstrated that epidermal expression of dominant negative 
Lef1 (K14ΔNLef1, Fig 9A) drives the formation ectopic SG (Fig 9B, nSG) along 
deformed HF. Epidermal fate is also stimulated resulting in cyst development. 
Additionally, the SG are enlarged (Niemann et al., 2002; Braun et al., 2003). These 
findings provoked the question whether formation of these ectopic SG originated from 
an unbalanced fate decision of HFSC or more committed TA cells. 
Fig 9: Formation of ectopic SG in K14ΔNLef1 mice 
(A) Schematic presentation of the K14ΔNLef1construct (Niemann et al., 2002).  
(B) Development of ectopic SG (nSG) along deformed HF shown by staining for sebocyte 
differentiation marker SCD1 (Fehrenschild et al., submitted) 
 
1.4.3 Deregulated Wnt/β-catenin signalling causes skin cancer 
Several studies provide evidence that de-regulated β-catenin signalling causes a 
variety of epithelial cancers, including skin tumours (Gat et al., 1998; Niemann and 
Watt, 2002; Owens and Watt, 2003; Polakis, 2000; Taipale and Beachy, 2001). 
Activating mutations have been found at a high frequency in human pilomatricomas 
(Chan et al., 1999) and the corresponding mouse models exhibit hair tumours 
(trichofolliculomas and pilomatricomas) (Gat et al., 1998). Conversely, mutations in 
the β-catenin binding domain of Lef1 have been found in a high frequency in human 
sebaceous tumours, indicating that also a repression of β-catenin-mediated Lef1 
signalling results in cancer development (Takeda et al., 2006). Interestingly, 
repressed β-catenin signalling in K14ΔNLef1 mice results to the development of 
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spontaneous sebaceous adenomas and papillomas with sebocyte differentiation 
tumours (Niemann et al., 2002). These tumours can also be induced: A single 
application of a sub threshold dose of a carcinogen (DMBA), leading to mutations in 
Ha-Ras, resulted in the formation of macroscopically visible sebaceous tumours 
within a time frame of 4 weeks (Niemann et al., 2007). The fast and defined 
development of sebaceous tumours provides an excellent tool to study early stages 
of tumour formation.  
Until now, it is not known which cell population is targeted by transformational events 
and gives rise to sebaceous tumours in K14ΔNLef1 mice.  
1.5 The rationale of cancer stem cells  
Previous studies have described that tumours are comprised of heterogeneous cell 
populations which differ in their phenotype and their proliferative capacity. It has been 
proposed that tumour growth is initiated by a subpopulation of cells, which are 
biologically different with respect to their functional abilities from the remaining bulk of 
the tumour. Therefore, a model has emerged to envision cancer as a hierarchical 
disease in which tumour growth is sustained by a population of cancer stem cells 
(CSC) (Lobo et al., 2007; Visvader and Lindeman, 2008; Wang and Dick, 2005). 
1.5.1 Characteristics of CSC 
Like tissue SC, CSC are multipotent and therefore could give rise to multiple cell 
lineages resulting in the heterogeneity observed in many tumours. CSC have the 
ability to self-renew and divide infrequently. This would explain the re-occurrence of 
tumours after chemotherapy, as proliferating (TA) cells are targeted and not 
transformed CSC sustaining tumour growth. In addition, CSC exhibit an unlimited 
proliferative potential and are able to recapitulate the cell types found in the originally 
tumour. Despite ongoing debates about the existence of true CSC (Adams and 
Strasser, 2008; Kelly et al., 2007), it is controversly discussed whether CSC arise 
from a transformed long-lived tissue SC accumulating mutations. Potentially, more 
committed or mature cells could be targeted by transformational events and aquire 
self-renewing potential thereby being transformed into CSC (Gupta et al., 2009). 
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1.5.2 Identification of CSC 
First evidence supporting the CSC hypothesis came from the hematopoetic system 
investigating acute myeloid lymphomas (AML) (Bonnet and Dick, 1997) and was 
followed by the identification of tumour-initiating cells in a variety of solid tumours 
including tumours in the central nervous and the respiratory system, the mammary 
gland, prostate, colon, head and neck squamous cell carcinomas and human 
melanomas (Al-Hajj et al., 2003; Collins and Maitland, 2006; Kim et al., 2005; O'Brien 
et al., 2007; Prince and Ailles, 2008; Schatton et al., 2008).  
Interestingly, there are first indications for the existence of CSC in skin tumours 
(Ambler and Maatta, 2009; Mancuso et al., 2006). It was found that tumourigenic 
CD34-expressing keratinocytes reside in murine squamous cell carcinomas (SCC) 
(Malanchi et al., 2008). More recently, lineage tracing experiments utilising a Cre-
sensitive tumour-mouse model for basal cell carcinoma (BCC), revealed that 
progenitor cells from the basal layer of the IFE and not from the HFSC niche 
contribute to BCC formation (Donovan, 2009; Youssef et al., 2010).  
 It still remains elusive how the surrounding microenvironment effects the 
conversion of a cell to a CSC. Furthermore, the identification of the cell of origin 
giving rise to a particular type of epidermal tumours will have major therapeutic 
implication to prevent and to treat cancer.  
1.5.3 Controversies 
In contrast to the hierarchical CSC model with a unique self-renewing cell type a 2nd 
model for tumour propagation has been postulated (Adams and Strasser, 2008; Kelly 
et al., 2007). This “clonal evolution“  model proposes that most of the tumour cells 
sustain tumour growth and have self-renewing capacity. Tumour heterogeneity in this 
context is ascribed not only to differentiation but also to intraclonal genetic and 
epigenetic variation and influences from the microenvironment. The clonal evolution 
model more attributes much of the intratumour variation to subclonal differences in 
mutational profile and all except the terminally differentiated cells may have some 
self-renewing capacity. Indeed, a collaborative action of both models is conceivable. 
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1.6 Objectives 
The multilayered epithelium of mammalian epidermis comprises the IFE, HF and SG. 
Functional SG release sebum into hair shaft and are important for barrier function 
and protection against pathogens and environmental assaults. The high cellular turn-
over of the SG requires a constant renewal of cells, suggesting stem or progenitor 
cells to be involved in SG homeostasis. To date, the cellular mechanism of SG 
regeneration still remains elusive. Although multiple SC/progenitor reservoirs have 
been defined within the epidermis, a functional relationship or hierarchy between the 
different niches is yet not fully understood. To assess whether multipotent SC from 
the underlying HFSC compartment regenerate the SG and give rise to these different 
SC/progenitor populations, an inducible Cre mouse model was generated during this 
PhD thesis to map the fate of individual HFSC-derived progeny. From these lineage 
tracing studies we aim to gain new insights into temporal and spatial control of SG 
renewal and epidermal regeneration during skin homeostasis.  
In addition, deregulated homeostasis leads to a variety of diseases including cancer. 
Previous studies have demonstrated that manipulation of Lef1, a key regulator of 
epidermal fate decision, drives ectopic SG formation resulting in sebaceous adenoma 
formation. Since mutant Lef1 in all keratinocytes of the basal layer promotes 
sebaceous commitment on expenses of HF regeneration, one objective of this thesis 
is to investigate whether an altered fate decision of HFSC-derived progeny drives the 
formation of ectopic SG. An additional issue is to identify the cells of origin 
contributing to the development of sebaceous tumours. Therefore, a major focus of 
the present study was to perform fate mapping analyses of HFSC-derived progeny 
during different stages of tumourigenesis. Over-expression of mutant Lef1 in the 
HFSC compartment will elucidate if deregulated Lef1 signalling in the HFSC niche is 
sufficient to drive tumour formation.  
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2 Material and Methods 
2.1 Chemicals and reagents 
Chemicals and reagents were purchased from Sigma-Aldrich, Merck or Roth unless 
stated otherwise. Enzymes used for experimental procedures are listed in Table 2. 
Oligonucleotides were synthesised by MWG Biotech.  
 Table 2: Molecularbiological enzymes 
enzyme company 
Eppendorf 5´prime DNA Taq polymerase Eppendorf 
RedTaq DNA polymerase Sigma-Aldrich 
High Fildelity Taq DNA polymerase Qiagen 
Phusion-Taq polymerase NEB 
T4 DNA ligase NEB 
restriction enzymes NEB 
Alkaline Phosphatase, Calf Intestinal CIP NEB 
 
2.2 Molecular Biology 
Unless designated otherwise, standard molecular procedures were carried out 
according to established protocols (Celis, 2006; Sambrook and Russel, 2001). 
2.2.1 Isolation of genomic DNA (gDNA) 
Tail biopsies of 3-week old mice were incubated in lysis buffer containing 0,2 M NaCl, 
0,1 M Tris/HCl, pH 8,5; 5 µM  EDTA; 0,2 % SDS and 100 µg/ml proteinase K (Sigma 
[39 U/mg]) for 3-4 hours at 55 °C. After a centrifugation step, 2 volumes 
isopropylalcohol were added to the supernatant to precipitate gDNA. 150 µl H2O 
(DNase free) was added to the pellet and subsequently, gDNA was dissolved o/n at 
RT. 
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2.2.2 PCR 
PCR was used to amplify DNA fragments for plasmid construction or to determine the 
genotype of the different mouse strains.  
For cloning procedures, fragments from plasmid DNA (see also Table 3) were 
amplified using either High fidelity Taq polymerase (cloning of K15ΔNLef1) of 
Phusion taq polymerase (cloning of K15CreER(G)T2 ).  
For cloning purposes, 50-200 ng plasmid DNA template was used and PCR reaction 
were performed and conditions optimised according to manufacturer´s guidelines.  
      Table 3: Used plasmids 
plasmid reference 
pEGFP Clonetech 
pK15CVM Liu et al., 2003 
pK14CreER(G)T2 Indra et al., 1999 
pSK2198∆NLef1 (Behrens et al., 1996) 
 
A maximum of 500 ng gDNA isolated from tail biopsies was employed for genotyping. 
The typical PCR sample contained within 25 µl volume 10 pmol of the two primer 
(Table 4), 25 µmol dNTPs, 1 U of RedTaq DNA polymerase and 1x Red taq Reaction 
buffer. The following PCR conditions were applied: 5 min, 94 °C initial denaturation, 
30 sec, 94 °C cyclic denaturation, 60 sec cyclic annealing at the appropriate 
temperature;  45 sec, 72 °C, cyclic elongation for a total of 30-35 cycles followed by a 
72 °C elongation step for 5 min. All PCR reactions were carried out either in T-
Gradient Thermocycler or Personal Thermocycler (Biometra). 
PCR amplification products were analysed by agarose gel electrophoresis.    
   Table 4: Oligonucleotides used for genotyping 
 
 
Mouse strain   oligonucleotide (5´-3´) 
K15CreER(G)T2 b-globfor GGA CAT CTT CCC ATT CTA AAC AAC ACC CTG K15for AGG TGG GCG GGC AGC TGT GTT TGT 
K14ΔNLef1 (Niemann et 
al., 2002) and K15ΔNLef1 
dNLef1for TGT CCC TTG TAT CAC CAT GGA CC 
dNLef1rev CCA AAG ATG ACT TGA TGT CGG CT 
R26RLacZ (Soriano et al., 
1999) and R26REYFP 
(Srinivas et al., 2001) 
YFP_1neu CCA AAG TCG CTC TGA GTT GTT ATC 
YFP_2 GCG AAG AGT TTG TCC TCA ACC 
YFP_3 wt GGA GCG GGA GAA ATG GAT ATG 
K14CreER(G)T2 (Indra et 
al., 1999) 
SC1 GTC CAA TTT ACT GAC CGT ACA C 
SC3 CTG TCA CTT GGT CGT GGC AGC 
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2.2.3 qRTPCR 
For quantitative real-time PCR experiments, total RNA of primary keratinocytes 
isolated from K14ΔNLef1 and control mice was purified using RNAeasy Plus Mini-Kit 
(Qiagen, Germany). For FACS-sorted cells, TRIZOL-reagent (Invitrogen) was used 
for RNA purification. QuantiTect Reverse Transcriptase Kit (Qiagen, Germany) was 
employed for cDNA-synthesis according to the manufacturer´s instructions. 
Quantitative PCR analyses were conducted using RT2 RT SYBR Green qPCR 
Master Mix (SuperArray Bioscience Cooperation, USA) and a StepOnePlus real time 
PCR system (Applied Biosystems). Particularly, the following PCR conditions were 
applied: 10 min 95 °C initial denaturation, cyclic denaturation at 95 °C for 15 sec 
followed by an annealing step at 60 °C for 1minute. Primer pairs were designed as 
shown in Table 5. Fold differences between primary keratinocytes derived from 
K14ΔNLef1 mice and age and sex-matched wild-type control animals were calculated 
based on the ΔΔCt method, adjusted to GapDH expression and are depicted as fold 
change normalized to wt expression. For analysis of mRNA expression levels of 
FACS-sorted cells changes were adjusted to 18S RNA expression and normalised to 
Itga6 positive keratinocytes. 
Table 5: Oligonucleotides used for qRT-PCR 
gene for oligo 5´-3´ rev oligo 5´-3´ 
mc-myc 
mcmycfor-
TGAGCCCCTAGTGCTGCATGAG 
mcmycrev-
ATGGAGATGAGCCCGACTCCGAC 
mNucleolin 
mNucleolinEx2for-
AAAACCCACGGTGAGGCCAA 
mNucleolinEx3rev-
CACCTTCTTTGCTGGGGTTGTG 
mSCD1 
mSCD1for-
GCTTCCACAACTACCACCACACCT 
mSCD1rev-
TGTGACTCCCGTCTCCAGTTCTCT 
CAATCC 
mBlimp1 
mBlimp1Ex2for-
GGCATCCTTACCAAGGAACCTGC 
mBlimp1Ex3rev-
GATGAGGGGTCCAAAGCGTG 
mKeratin6a 
mK6aEx5for-
ATCGCTGAGGTCAAGGCCCAGTA 
mK6aEx6rev- 
GCTTGGTGTTGCGTAGGTCG 
mLgr6 
mLgr6Ex15for-
AGGGAACTTGGCCCTGTCTC 
mLgr6Ex16rev-
GGATGAAAGTCCTCGGCCTG 
mCD34 
mCD34Ex2for-
GGACAGCAGTAAGACCACACCAGC 
mCD34Ex3rev-
AGGCAGTATGCCAGTTGGGGA 
mK15 
mK15Ex3for-
TGGAGATGCAGATTGAGCAGCTGAA 
mK15Ex4rev-
TGCTCCCTCATCTCTGCCAGCA 
mItga6 
ma6ItgEx4for-
AAGTTTGGCTCCTGTCAGCAAGG 
ma6ItgEx5- 
CTGTTAGCAGGAACGGGCACGA 
mTenascinC 
mTenascinCEx6for-
TACCGCCAAACTGGCCTTGCTC 
mTenascinCEx7rev-
TGAACCAGGTGATCAGTGCTGTGG 
mNFATC1 
mNFATc1for 
TGCtGAGCAGTATCTGTCGGTGC 
mNFATc1rev  
TGTGGTGAGACTTGGGCTGC 
mGapDH 
mGapDHfor-
ACCTTTGGCATTGTGGAAGG 
mGapDHrev- 
ACACATTGGGGGTAGGAACA 
m18S 
m18Sfor- 
CCTGCCCTTTGTACAC 
m18Srev- 
CGATCCGAGGGCCTCAC 
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2.2.4 Agarose gel electrophoresis and DNA gel extraction 
Following PCR amplfication or treatment of DNA with restriction enzymes resulting 
DNA fragments of different sizes were separated by agarose gel electrophoresis (0.2-
2 % (w/v) agarose in 1xTAE electrophoresis buffer).  
For cloning purposes, large DNA fragments ranging from 1.5-8 kb were exised and 
DNA was eluted using NucleoGelExtractionII kit (Macherey&Nagel).  
Alternatively, small PCR-amplified or digested DNA fragments (up to 1 kb) were 
purifed using NucleoSpinExtractionII kit (Macherey&Nagel).  
The right size of the isolated DNA fragments was always verified by an analytical 
agarose gel electrophoresis (100V). The concentration of the DNA was determined 
by measuring the sample absorption at 260nm with a spectrophotometer 
(Eppendorf). Purity of the DNA was assessed by calculating the ratio of absorption at 
260nm versus 280nm.  
2.2.5 Cloning procedures 
2.2.5.1 Transformation and isolation of plasmid DNA  
Ligated plasmid DNA was introduced into chemo competent bacteria (TZ101α 
Trenzyme) using heat shock transformation. Plasmid DNA was isolated either using 
QiagenMiniPrep or Maxiprep kit.  
2.2.5.2 Cloning of pK15CreER(G)T2  
To generate the plasmid pK15CreER(G)T2, a 5 kb K15 promotor fragment (Liu et al., 
2003) was cloned into the K14CreER(G)T2 vector (Indra et al., 1999) after the K14 
regulatory sequence had been removed by SalI digest (Fig 10). In particular, the 
K14CreER(G)T2 vector is comprised of an inducible Cre recombinase, a rabbit β-
globin Intron II sequence enhance transgene expression and a polyAAA tail to 
prevente exonucleatic RNA degradation. The K15 promotor fragment was PCR-
amplified from pBK15CVM plasmid (Liu et al., 2003). The addition of SalI restriction 
sites introduced by both primers allowed the insertion of the K15 promotor fragment 
into the CreER(G)T2 vector. Ligated vector (CreER(G)T2) and insert (K15) was 
introduced into chemo-competent bacteria TZ101α (Trenzyme) using heat shock 
transformation. To allow growth of bacteria transformed with pK15CreER(G)T2 
special media conditions were employed (LB medium containing 0.05 % glucose and: 
100 µg/ml ampicillin for selection). Positive clones were identified using XhoI / PacI 
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double digests. Right nucleotide sequence was proven by sequencing (performed by 
the CMMC service unit). 
K15 promotor (5kb)
pBK-CVM
(4.5kb)
Amplificationof K15 promotor (5kb) via PCR
Pfor (5´-ataagtcgacctgagctaccagcgagactcc-3´)
Prev (5´-aatagtcgacttcctgtccctagcaagcaggagag-3´)
Integration of SalI-restriction sites
K15 promotor (5kb)SalI SalI
SalI-digestion
K14 promotor (2kb) b-globinIntron II Cre-ER(G)T2
dmc
pK14Cre-ER(G)T2
(8.236kb)
SalI SalI
SalI digestion
pK15CVM
(9.5kb)
Dephosphosphorylation
via CIP
Isolation of 6.26kb fragment, 
Removement of K14-promotor
b-globin
Intron II Cre-ER(G)T2
Cre-ER(G)T2
(6.236kb)
SalI SalI
dmc
b-globin
Intron II Cre-ER(G)T2
pK15Cre-ER(G)T2
(11.236kb)
SalI SalI
K15 promotor
Ligation and Transformation
into TZ101α
dmc
PacI XhoI
Cloning of K15CreER(G)T2
K15pBKCVM: optained from G. Cotsarelis
(described in Lui et al., 2003)
K14CreER(G)T2: optained from Metzger/Chambon
(described in Li et al., 2000)
 
 
 
Fig 10: Scheme depicting cloning procedure for generating pK15CreER(G)T2 (see also 
text) 
2.2.5.3 Purification of K15CreER(G)T2 for microinjection 
NotI digestion was performed to linearise the construct and to delete vector backbone 
not required for successful microinjection. The resulting 8 kb DNA fragment was 
purified using gel extraction and strained through a 0.45µm filter (Millipore) to ensure 
high quality for microinjection. 
2.2.5.4 Cloning of pK15ΔNLef1  
To generate the plasmid pK15ΔNLef1, pK15CreER(G)T2 was partially digested with 
EcoRI to remove CreER(G)T2 (Fig 11). Accessorily to the amplification of myc-
tagged ΔNLef1, EcoRI restriction sites were added for subsequent ligation into 
EcoRI-digested pK15CreER(G)T2. Using heat shock transformation, DNA was 
introduced into chemo competent bacteria (TZ101α, Trenzyme). Again, 0.05% 
glucose and 100 µg/ml ampicillin was added to the medium. Plasmid DNA of 150 
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clones was isolated and PCR was performed amplifying K15 or ΔNLef1 fragment to 
identify positive clones that carried pK15ΔNLef1. Plasmid DNA was sequenced to 
confirm the right nucleotide sequence of positive clones (performed by the CMMC 
service lab).  
pSK
K15 promotor (5kb) b-globinIntron II Cre-ER(G)T2
dmc
pK15Cre-ER(G)T2
(10.236kb)
Removement of CreER(G)T2 
EcoRI digestion
ΔNLef1
(Pl.2987)
Dephosphosphorylation
via CIP
b-globin
Intron II
pK15
dmc
b-globin
Intron II
pK15ΔNLef1
(9.436kb)
SalI SalI
K15 promotor
Ligation and Transformation into TZ101α
media conditions: +Amp [100µg/ml]
+ 0.05% Glc
dmc
Cloning of K15ΔNLef1
ΔNLef1Myc-tag
SpeI KpnI
Amplification of dNLef1 via PCR
Integration of EcoRI-sites
Purification and EcoRI-digestion
EcoRI EcoRI
K15 promotor (5kb)EcoRI
EcoRI EcoRI
ΔNLef1Myc-tag
SpeI KpnI
ΔNLef1Myc-tag
SpeI KpnI
ΔNLef1
(1.164kb)
 
 
 
Fig 11: Schematic representation of cloning procedures for generating pK15ΔNLef1 
2.2.5.5 Purification of K15ΔNLef1 for microinjection 
NotI digestions were carried out to linearise and a 7 kb DNA fragment containing the  
K15ΔNLef1 expression cassette was purified by agarose gel extraction. DNA was 
addtionally strained through a 0.45µm filter (Millipore) to ensure high quality of the 
construct for microinjection (Millipore columns).  
2.2.5.6 DNA sequencing 
Plasmid DNA was sequenced using a ABI Big Dye Terminator Sequencing Kit 
(Applied Biosystems) according to the manufacturer´s instructions. The fluorescently 
labelled DNA was analysed with an ABI Prism3730 DNA analyser (Applied 
Biosystems).  
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2.3 Cell biology 
2.3.1 Histological analyses 
Sections of formaline-fixed and paraffin-embedded back or tail skin and tumour tissue 
(7-10 µm) were dehydrated. Subsequently, hematoxylin/eosin (H/E) staining was 
performed according to the standard protocols. Alternatively, skin sections (4-7 µm) 
of OCT-embedded frozen tissue were fixed with 4 % (w/v) PFA and subjected for 
further immunofluorescent analyses.  
2.3.1.1 Immunofluorescent stainings  
Fixed epidermal sheets were blocked for 1 h with PB buffer containing 0.5 % milk 
powder, 0.25 % fish skin gelatine and 0.5 % TritonX-100 in TBS (20 mM HEPES, pH 
7.2, 0.9 % NaCl) (Braun et al., 2003). Following o/n incubation with primary 
antibodies at RT (gentle agitation), whole-mounts were washed with PBS-0.2 % 
Tween-20 for 4 h. Secondary antibodies were then applied o/n at RT and washing 
steps were repeated for 4 h. Epidermal sheets were rinsed with distilled water before 
mounting with Mowiol/DABCO. To detect EYFP expression in skin sections, tissue 
was fixed with 4% PFA for 3 hours at RT. After an incubation with 30% sucrose (o/n, 
4°C), skin was OCT-embedded and cryo sections (5-50µm) were analysed for YFP 
expression. 
2.3.1.2 Antibodies 
The antibodies listed in Table 6 were used applying protocols described previously 
(Braun et al., 2003).  
 Table 6: Used antibodies 
antibody host dilution reference 
K15 mouse IgG2a 1:1000 Neomarkers 
K15 guinea pig 1:1500 Progen 
GFP rabbit 1:2500 Molecular Probes 
Cre rabbit 1:750 Covance 
SCD1 goat 1:150 Santa Cruz 
Itga6 rat 1:3000 BD Bioscience 
CD34 rat 1:50 E-Bioscience/Natutec 
MTS24 rat 1:100 Gill et al., 2002 
NG2 rabbit 1:250 Calbiochem 
ScaI-PE rat 1:250 BD Bioscience 
Sox9 rabbit 1:150 Santa Cruz 
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All secondary antibodies Alexa-488, -594, Cy3 were obtained from Molecular Probes. 
In some cases, propidium iodide (PI, 1:2000) or DAPI (1:2000) was used for nuclear 
counterstain. Immunostainings were analysed and images taken applying confocal 
microscopy (Zeiss LSM711). For 3-dimensional evaluation of epidermal whole 
mounts, 15-30 stacks of 2.5µm size were taken and projected in a maximum intensity 
using ImageJ (NIH).  
 
2.3.2 β-Galactosidase staining in vivo / in vitro 
β-galactosidase staining was conducted as described earlier (Morris et al., 2004). 
Skin tissue and epidermal whole-mounts were fixed with 0.2 % glutaraldehyde/2 % 
formaldehyde for 1.5 h. Alternatively, a fixation of keratinocytes with 4 % PFA was 
followed by a permeabilisation step (washing buffer). After a washing step with 
potassium phosphate-buffer (KPP) containing EGTA [0.05M], MgCl2[0.02M] and 
0.02 % NP-40, samples were incubated with X-Gal staining solution (0.5 mg/ml X-
Gal, 10 mM K3[Fe(CN)6], 10 mM K4[Fe(CN)6 in KPP 0.1 M, pH 7.4; 0.02 % NP-40) 
o/n at RT. Following a washing step o/n, RT, X-Gal treated paraffin and cryo sections 
(4-10 µm) or whole-mounts were counterstained with hematoxylin and analysed by 
light microscopy (LeicaDM4000B).  
2.3.3 Isolation of primary keratinocytes  
The skin of 3-4 days old mice was harvested and subsequently digested with 0.25 % 
trypsin/EDTA 0.02 % o/n at 4°C. Epidermis was separated from underlying dermal 
tissue and minced (Rheinwald, 1989; Rheinwald and Green, 1975; Watt, 1994). 
Primary keratinocytes of adult back skin were isolated as described earlier (Blanpain 
et al., 2004; Jensen et al., 2009). Briefly, subcutaneous and fat tissue of 6-8 weeks 
old mice was removed manually and back and tail skin were digested with 0.25 % 
trypsin (without EDTA, GIBCO/Invitrogen) for 2-2.5 h at 37 °C, 5 % CO2. 
Subsequently, epidermis was pealed off, minced and gently agitated for 20 min at RT 
in defined keratinocyte medium (chapter 2.3.4 and (Watt, 1994) at RT).  
After straining through a 70 µm filter, cell suspensions derived from 2-4 days old and 
adult mice were centrifuged (1000 x g, 15 min, 4 °C). Resuspended keratinocytes 
were seeded on Collagen G coated [0.04mg/ml] 10 cm plates. Keratinocytes were 
grown in co-cultures with mitomycin [4µg/ml]-treated anti-proliferative J2 3T3 feeder 
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cells (Swiss Albino) (Rheinwald and Green, 1975; Watt, 1994). K14, Itga6 staining 
(FACS-analysis, immunostaings) were performed to confirm epidermal deprivation of 
the isolated cells.  
2.3.4 Cultivation of cells  
Primary keratinocytes were co-cultured with anti-proliferative JT3T3 cellls in defined 
low calcium keratinocyte medium containing DMEM/Ham's F12 (3:1) (<50 µM Ca2+, 
Biochrom) supplemented with penicillin (100 IU/ml), streptomycin (100 µg/ml), 
adenine (1.8 x 10–4 M), gluthamine (2 mM), hydrocortisone (0.5 µg/ml), epidermal 
growth factor (EGF) (10 ng/ml), cholera enterotoxin (10–5 M), and insulin (5 µg/ml) and 
10 % fetal calf serum (FCS Gold) at 32 °C in an atmosphere of 5 % CO2 in a 
huminified incubator  (Carroll et al., 1995; Morris et al., 1987; Rheinwald, 1989; 
Rheinwald and Green, 1975). To avoid differentiation of keratinocytes which can be 
induced by Ca2+, FSC was treated with Chelex-100 resin (BioRad) o/n, RT, pH 7.0 
and was strained through a sterile filter prior to use.  
J23T3 fibroblast were cultured in DMEM supplemented with 10 % FCS, penicillin 
(100 U/ml) and streptomycin (100 µg/ml) at 37 °C and 5 %CO2.  
2.3.5 Passaging of cells 
Medium was changed every 2-3 days. When keratinocyte reached confluency of 80-
90 %, cells were washed with PBS-0.02 % EDTA and incubated with 0.05 % (w/v) 
trypsin/0.02 % (w/v) EDTA (Gibco/Invitrogen) at 37 °C until the anti-proliferative 
feeder cells detached. Cells were passaged 1:2 on collagen-coated culture dishes. 
To freeze keratinocytes, cell suspensions were mixed with 10 % (v/v) DMSO in FSC-
Gold+Chelex and were gradually frozen down using a “Cryo 1°C freezing container” 
(Nalgene). For long-term storage, keratinocytes were transferred into liquid nitrogen.  
J23T3 feeder cells were passaged by washing with PBS at RT and incubation with 
0.05 % (w/v) trypsin/0.02 % (w/v) EDTA for 2 min at 37 °C. For co-culturing with 
primary keratinocytes, J23T2 cells were treated with mitomycin [4µg/ml] for 1.5 hours 
to stop proliferation. 
2.3.6 FACS-sorting 
Keratinocytes were isolated as described above (2.3.3). For Lrig1-staining, epidermis 
of back skin was harvested and digested using thermolysin (Sigma-Aldrich) (Jensen 
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et al., 2009). Single cell suspensions were incubated with the following antibodies in 
5 % FCS/PBS for 45 min at 4 °C: phycoerythrin (PE)-conjugated α6-integrin (CD47f, 
BD Pharmingen; 1:25), Alexa488-coupled CD34 (Ram34, eBioscience; diluted 1:10), 
Lrig1 (R&D Systems; 1:20). Cell viability was assessed by propidium iodide (PI) 
labelling. Subsequent cell sorting for RNA isolation and expression analysis were 
carried out using a FACSVantage SE System (BD Bioscience). 
2.3.7 Transfection of primary keratinocytes 
Transfection of primary keratinocytes was carried out using lipofectamin2000 
(Invitrogen) according to the manufacturer’s instructions. DNA amount and 
relationship between lipofectamin and DNA was optimised using a pEGFP vector. 
Maximal transfection efficiency ranged from 15-20 % when using 1-4 µg of DNA.  
2.3.8 Tamoxifen treatment in vitro  
Primary keratinocytes derived from R26RLacZ or wt mice were transfected with 
pK14CreER(G)T2 or pK15CreER(G)T2-DNA (2.3.7). Cre recombinase was induced 
in transfected keratinocytes with the incubation of 0.2 µM 4-hydroxytamoxifen (4-
OHT, Sigma-Aldrich, dissolved in EtOH) for 12 h. Cells were analyzed for Cre 
reporter gene expression 24 h after transfection. For appropriate induction of Cre 
recombinase, it is essential to use Optimem or SFM defined keratinocyte (Invitrogen), 
media that do not contain any pH-indicators or colorants, since these might lead to 
unspecific Cre-activation.  
2.4 In vivo studies 
All experimental procedures applying different mouse models were performed in 
according to institutional guidelines and animal license given by the State Office 
North Rhine Westphalia. 
2.4.1 Mouse models 
All mouse strains used were backcrossed or maintained on a C57Bl/6 background.  
2.4.1.1 Generation of K15CreER(G)T2 
8 ng/µl of linearised and purified K15CreER(G)T2-DNA was introduced into 250 
fertilised oocytes (performed by the CMMC microinjection lab). Subsequent 
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transplantation of the micro-injected oocytes into different pseudo-pregnant foster 
mice resulted in the birth of 34 founder animals. Vitality and quality of the micro-
injected oocytes was confirmed by light microscopy.  
2.4.1.2 Generation of K15ΔNLef1 
A 7 kb DNA fragment containing the K15ΔNLef1 expression cassette [5 ng/µl] was 
injected into the pronucleus of fertilised ooyctes. The transplantation of 300 of these 
oocytes into different fosters generated 54 F0-mice.  
2.4.1.3 Cre-reporter lines 
To monitor and visualise specificity of Cre recombination and enzyme activity in vivo, 
inducible Cre-strains were either crossed with R26RLacZ (Soriano, 1999) or to 
R26REYFP Cre-reporter mice (Srinivas et al., 2001). To maximise visualisation of 
positive recombination, Cre-reporter lines were kept in a homozygous background.  
2.4.1.4 K14ΔNLef1 
To study effects of impaired Lef1 signalling on the fate of labelled bulge cells, 
K15CreER(G)T2 (A_C_line)/ R26REYFP were crossed with K14ΔNLef1 mice 
(Niemann et al., 2002).  
2.4.2 Tumour experiments 
To initiate tumourigenesis, 7 week old K14ΔNLef1, K15ΔNLef1 mice and wt control 
littermates were treated once with a sub-critical threshold dose (100 or 150 nM 
dissolved in 200 ml acetone) of 7,12-dimethylbenz(a)anthracene (DMBA, Sigma-
Aldrich). 3-4 weeks after topical DMBA application tumors developed as described 
earlier (Niemann et al., 2002).  
2.4.3 Tamoxifen treatment 
Tamoxifen substance (Sigma-Aldrich) was dissolved in 200 µl sun flower oil for 1 
hour under vigourous shaking (Indra et al., 1999). A dose of 2.5 mg/day was injected 
intraperitoneally at three consecutive days. In alternative experiments, a single dose 
of 4 mg tamoxifen was used. Intraperitoneal injections were more efficient than 
topical application of the same dose of tamoxifen. To apply the tamoxifen in the 
appropriate phase of the hair cycle, animals were shaved, the current hair cycle 
phase was determined (according to (Muller-Rover et al., 2001) and Cre 
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recombinase was induced in early telogen (PD42-52), telogen to anagen transition 
(PD53-55) and anagen (PD56-71). 
2.4.4 Generation of label retaining cells (LRC) 
To generate LRC (Bickenbach et al., 1986; Bickenbach and Chism, 1998), mice 
(PD9/10) were injected with 50 mg/kg bodyweight 5-bromo-2'-deoxyuridine (BrdU, 
Sigma-Aldrich, Germany) every 12 h for a total pulse of four intraperitoneal injections 
(Braun et al., 2003). Mice were analysed for LRC 6-8 weeks post injection. For short-
term labelling, a dose of 100 mg/kg BrdU was used. Tissue was harvested 1.5 h post 
injection. 
2.4.5 Tissue harvesting 
Mice were sacrificed and tail, back skin or tumour tissue was dissected as described 
(Paus et al., 1999). Tissue was either fixed directly (1.5 h, 4 % formaldehyde or 0.2% 
glutaradehyde/2% formaldehyde at RT) for paraffin embedding or stored at -80°C 
embedded in tissue Tec OCT (tissue freezing medium, Sakura) to perform cryo-
sections.  
Addtionally, samples were directly transferred into liquid nitrogen for RNA or protein 
analyses.  
2.4.5.1 Isolation of epidermal whole mounts 
Epidermal whole-mounts of tail skin were isolated as described before (Braun et al., 
2003). Briefly, tail skin was incubated in 5 mM EDTA, 37 °C for 4 h and epidermis 
was separated from the underlying dermis. To prepare whole mounts from early 
lesions and epidermal tumours, early lesions and sebaceous tumours from 
K14ΔNLef1 mice were dissected and fat tissue and most of the connective tissue 
was removed using forceps. Following an EDTA [20 mM] -treatment at 37 °C for 3.5 
to 4.5 h, the epidermis was gently peeled off using forceps.  
Epidermal sheets of tail, back and early sebaceous tumours were fixed in 3.4% 
formalaldehyde or in 0.2 % glutaraldehyde/2 % formaldehyde for 2 h at RT.  
Fixed whole mounts were stored at 4 °C in PBS.  
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2.5 Statistical analysis 
Epidermal whole-mounts of induced A_K15CreER(G)T2/R26RLacZ were analysed 
for LacZ positive cells at different tracing time points (day 1 to 7 after Cre induction). 
After counting a minimum of n=120 telogen HF of 3 independent mice per tracing 
time point, we classified the LacZ positive cells concerning their expression pattern, 
namely bulge (B) bulge only; B, B + SD + SG (more complex pattern) and SG + SD. 
S.D. was calculated. To test the significance between labelled bulge cells per 
pilosebaceous unit between d3 and 6months of tracing (n=3 mice/time point), 
students t-test was employed to determine the p-value.  
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3 Results 
3.1 Epidermal regeneration during skin homeostasis 
Mammalian epidermis is a highly dynamic epithelium comprising the IFE, HF and 
associated SG. Tissue integrity and the individual cellular turn over of each of these 
compartments is maintained by multiple SC and progenitor populations (Blanpain and 
Fuchs, 2009, Jaks et al., 2010). 
3.1.1 Stem cell and progenitor niches within the epidermis  
In a first set of experiments, the expression pattern of different described 
SC/progenitor markers was analysed by immunofluorescent studies on epidermal tail 
whole-mounts. The whole-mount technique provides an excellent tool to screen and 
visualise large areas of tail epidermis in a three dimensional (3D) fashion (Braun et 
al., 2003). Physiologically, pilosebaceous units of tail skin are organised in triplicates 
and comprise two SG attached to one HF.  
First, we investigated the HFSC niche (HF bulge) (Fig 12A), which was 
recognised by K15 (Fig 12B), CD34 (Fig 12E), Itga6 (Fig 12D) antibodies. Notably, 
LRC were not only detected in the bulge of telogen HF (Fig 12C, arrowhead), but the 
BrdU label was also diluted along the UI and the SG (Fig 12C, arrows) and 
downwards to the HF indicating a contribution of HFSC from the bulge to these 
compartments. The transcription factor Sox9 showed a heterogeneous expression in 
the bulge region (Fig 12F, arrowheads) and Sox9+ve cells were seen in the 
developing HF (Fig  12F, arrows).  
Additional SC and progenitor cell populations of the pilosebaceous unit have 
been identified residing above the HF bulge (Fig 12G). The region of the UI, located 
between the HFSC niche and the SG, shows low Itga6 expression and lacks CD34 
and ScaI (Fig 12 D,E,K and Jensen et al, 2008). The UI is positive for the MTS24 
antigen (Nijhof et al., 2006), which is a progenitor marker for the thymic epithelium 
(Gill et al., 2002) and has recently been identified to correspond to Plet1 (Depreter et 
al., 2008, Raymond et al., 2010). Besides a positive signal in the UI, MTS24 
antigen+ve cells were also detected at the outer periphery of the SG (Fig 12H).  
The JZ, just adjacent to the SG, has recently been reported to contain bipotent 
Lrig1+ve SC giving rise to the IFE and the SG. Consistent with previous reports 
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(Jensen et al., 2009) the transmembrane protein Lrig1 was detected within the JZ 
and periphery of the SG (Fig 12I, arrow).  
Next, we analysed Blimp1 expression, a transcription factor that has been 
proposed to mark unipotent progenitor cells at the SG in murine epidermis (Horsley 
et al., 2006). In contrast, a recent study analysing human skin and tumour tissue 
revealed that Blimp1 expression was restricted to more differentiated sebocytes 
(Sellmeyer and Krall, 2009). Although Blimp1 antibody showed a positive signal in 
the SG in epidermal tail whole-mounts (Fig 12J), no expected nuclear staining was 
seen.  
NG2 (chondroitin sulfate proteoglycan) was described to be a surface marker 
for progenitors in human IFE (Ghali et al., 2004; Legg et al., 2003). In murine tail 
epidermis, a NG2+ve signal was not only observed in the IFE but also in the HF and 
UI, indicating that NG2 in murine tail epidermis does not restrictively mark progenitors 
of the IFE (Fig 12L).  
 Taken together, we were able to detect a series of SC/progenitor markers in 
epidermal whole-mounts of tail skin, thereby providing the tools to study the 
dynamics of spontaneous epidermal regeneration.  
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Fig 12: Different SC/progenitor compartments within the epidermis 
Immunofluorescent studies on epidermal whole-mounts from 7-8weeks old wt mice (early 
anagen/anagen) using the indicated antibodies against SC/progenitor markers.  
(A) Localisation and markers of the HF bulge. (B-F) Expression of K15, LRC, Itga6high, CD34 
and Sox9 in the HF bulge. Note that LRC were diluted towards the HF and UI/SG (C, 
arrows). Sox9+ve cells were also detected at the HF (F, arrows). (G) Markers for 
SC/progenitor niches lying above the HF bulge. (H) MTS24 anitgen is expressed at the UI 
and the periphery of the SG. (I) Lrig1 detected the JZ and periphery of the SG. (J) Blimp1 
antibody recognised cells localised to the SG, but no nuclear signal was seen. (K) ScaI is 
confined to the INF and IFE interspersing the pilosebaceous units. (L) NG2 marked the HF 
and IFE. HF-hair follicle, UI-upper isthmus, JZ-junctional zone, SG-sebaceous gland, B-
bulge, INF-infundibulum, IFE-interfollicular epidermis. Scale bars in C,F,I,J represent 80 µm, 
in K and L (inset) 40 µm. 
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3.2 Generation of K15CreER(G)T2 transgenic mice 
To investigate a potential contribution of HFSC to epidermal regeneration and 
tumourigenesis, we have generated K15CreER(G)T2 transgenic mice (Fig 13). This 
mouse model expresses a tamoxifen-inducible CreER(G)T2-system (Indra et al., 
1999) under the control of the Keratin 15 (K15) regulatory sequence. This 5 kb K15 
promotor fragment has previously been shown to specifically target HFSC from the 
bulge region and K15+ve progenitors contribute to HF regeneration (Liu et al., 2003, 
Morris et al., 2004). With the site-specific targeting of CreER(G)T2 under the the 
control of the K15 promotor, we aim to conditionally induce Cre-recombinase in 
HFSC of the bulge region. The CreER(G)T2 system consists of a Cre-recombinase 
fused to a modifed ligand binding domain of the human estrogen receptor (ER(G)T2), 
which carries a triple mutation in G400V/M543A/L544A (Indra et al., 1999).  
Upon application of the estrogen analogon tamoxifen to K15CreER(G)T2 mice, Cre-
recombinase is translocated to the nucleus and therefore becomes active. Crossing 
K15CreER(G)T2 mice to Cre-sensitive reporter lines (Rosa26RLacZ, Soriano, 1999; 
R26REYFP, Srinivas et al., 2001) provides an excellent tool to trace all cell lineages 
descending from the originally labelled HFSC (HFSC-derived progeny). This involves 
Cre-mediated removement of a loxP-flanked transcriptional termination sequence in 
front of the reporter genes (such as LacZ or EYFP) leading to a constitutive 
expression of LacZ or EYFP. As a result, not only HFSC but also HFSC-derived 
progeny could be visualised and traced over a certain period of time.  
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Fig 13: Generation of K15CreER(G)T2 mice to target HFSC and to map HFSC-derived 
progeny 
Tamoxifen treatment of K15CreER(G)T2 mice leads to the activation of Cre recombinase in 
keratinocytes carrying the K15 promotor fragment. By crossing K15CreER(G)T2 to 
R26REYFP/LacZ Cre reporter mice, Cre mediated recombination leads to a constitutive 
reporter gene expression (LacZ or EYFP).  
3.2.1 Cloning of pK15CreER(G)T2 
To generate K15CreER(G)T2 transgenic mice, a 5 kb K15 promotor fragment (Liu et 
al., 2003) was amplified (Fig 14). The K15promotor fragment was exchanged with the 
K14promotor fragment of pK14CreER(G)T2 (Indra et al.1999). The pK14CreER(G)T2 
vector consists of a rabbit β-globin intronII sequence downstream of the promotor to 
enhance transgene expression and a polyAAA tail to prevent exonucleatic RNA 
degradation (Fig 14); detailed cloning procedure in 2.2.5.2.).  
 
Fig 14: Scheme depicting the K15CreER(G)T2 construct 
A 5 kb K15 promotor fragment was used to drive an inducible CreER(G)T2. The CreER(G)T2 
vector is comprised of an inducible CreER(G)T2, an enhancer (β-globin intronII) and a 
polyAAA tail. NotI restriction sites were used to linearise the construct for microinjection .  
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Next, we analysed if cloned pK15CreER(G)T2 DNA exhibited the correct size, 
orientation and sequence. Therefore, plasmid DNA isolated from potenial 
pK15CreER(G)T2 clones was digested with PacI enzyme which linearised the 
construct resulting in a fragment of an expected size of 11 kb (Fig15B). Double 
digests using XhoI (restriction site at +1) and PacI (restriction site at +0.8 kb) (Fig 
15A) were used to verify the right insertion of the K15 promotor fragment. As 
expected, fragments of 6 and 4.8 kb were obtained (Fig 15B). Additional sequence 
analyses (performed by the CMMC service lab) affirmed the correct sequence of 
pK15CreER(G)T2 plasmid DNA.  
 
Fig15: Generation of pK15CreER(G)T2 
(A) Map depicting restriction sites of pK15CreER(G)T2. (B) K15CreER(G)T2-derived plasmid 
DNA was digested to verify correct size and orientation of the construct. PacI linearised the 
pK15CreER(G)T2 and PacI / XhoI double digests showed expected fragments of 6 and 
4.75kb size.  
 
3.2.2 Functionality of pK15CreER(G)T2 in vitro 
To test whether the pK15CreER(G)T2 construct indeed expresses CreER(G)T2 and 
if Cre recombinase can be specifically activated by the application of tamoxifen, 
primary keratinocytes derived from LacZCre-reporter mice (R26RLacZ) were 
transfected with pK15CreER(G)T2. Subsequently, Cre recombinase was induced by 
adding 0.2 µM 4-hydroxytamoxifen (4OHT) for 12 hours. 24 hours following 
transfection, Cre-mediated recombination was visualised and quantified by the 
detection of LacZ. 2 % of pK15CreER(G)T2 transfected keratinocytes exihibited β-
Galactosidase activity (Fig 16, arrows), respectively. Transfections using 
pK14CreER(G)T2 (targets basal keratinocytes) revealed 25 % of the counted cells to 
be LacZ+ve and served as positive control (Fig 16B), since K14 is more widely 
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expressed in basal keratinocytes. Therefore, more LacZ+ve cells were detected in 
pK14CreER(G)T2-transfected keratinocytes compared to pK15CreER(G)T2-
transfected cells. No specific signal was observed in pK14/pK15CreER(G)T2-
transfected vehicle (EtOH) controls (Fig 16 C,D). Tamoxifen treatment of 
keratinocytes from wt mice never resulted in the detection of LacZ+ve cells Fig 16E, 
F). 
These data demonstrate that Cre recombinase of pK15CreER(G)T2 could be 
specifically activated by the application of 4-hydroxy-tamoxifen and was functional in 
vitro.  
Fig 16: pK15CreER(G)T2 is inducible and active in vitro  
Primary keratinocytes derived from R26RLacZ-Cre-reporter or wt mice were transfected with 
the indicated plasmids and treated with 0.2 µM 4OHT for 12 h. Fixed cells were analysed for 
LacZ expression 24 h after transfection. LacZ+ve recombinants (arrows) were detected when 
transfecting R26RLacZ-derived primary keratinocytes with pK15CreER(G)T2 (A) or 
pK14CreER(G)T2 (B). No specific signal was observed in pK15/pK14CreER(G)T2-
transfected R26RLacZ-derived keratinocytes after treatment with vehicle alone (C,D) or in 
transfected wt keratinocytes treated with 4OHT (E,F). Scale bars represent 100 µm.  
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3.2.3 Identification of K15CreER(G)T2 founder lines 
Having verified the functionality in vitro, pK15CreER(G)T2-DNA was linearised and 
purified for microinjection. Therefore, NotI digest was performed to exclude 
sequences of the vector backbone not required for transgene expression. A 8 kb 
DNA fragment was isolated and purified. An additional purification step was 
performed to ensure a high quality of the DNA fragment. Quality, size and quantity 
were determined by a subsequent analytic agarose gel electrophoresis. 
 Linearised DNA of K15CreER(G)T2 [8ng/µl] was introduced into the 
pronucleus of approximately 250 fertilised oocytes. Subsequently, oocytes were 
transplanted into 40 pseudo-pregnant foster mice (performed by the CMMC 
microinjection lab). Genomic DNA isolated from the offspring (F0-generation) was 
analysed for K15CreER(G)T2 expression. Convential PCR analysis amplifying a 
fragment of 290bp size covering a sequence from the K15 promotor and the β-globin 
intronII revealed that 8 out of 34 mice carried the transgene (Fig 17, highlighted in 
bold). The transgene could also be amplified using genomic gDNA derived from F1-
generation, demonstrating germline transmission of the transgene. All founder mice 
showed a normal postnatal development, although 2 founder lines (founder F and H 
line) were infertile.  
Fig 17: Identification of K15CreER(G)T2 founder lines 
Performing PCR on genomic DNA isolated from tail biopsies, 8 positive founder lines could 
be identified (highlighted in bold, referred to A-H line). No signal was observed in the 
negative control (-), wheras in the positive control (+, pK15CreER(G)T2) an amplificate at the 
right size (290bp) could be detected. 
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 To test whether Cre recombinase can specifically be activated in K15+ve cells 
from the HFSC in vivo, the F1-generation of each founder line was crossed to Cre-
reporter mice (either R26RLacZ or R26REYFP).  
3.2.4 Specific targeting of bulge cells using K15CreER(G)T2 mice 
3.2.4.1 Optimisation of the application and detection protocol using 
K14CreER(G)T2 mice 
In a first set of experiments, K14CreER(G)T2 mice (targeting all proliferating (TA) 
cells of the basal layer, (Fig 18B) crossed to Cre-reporter were used as positive 
control to optimise the dose and duration of tamoxifen-treatment as well as the 
detection method to specifically visualise positive recombinants in epidermal tail 
whole-mounts and back skin sections. The following Cre-reporter lines were tested: 
Rosa26LacZ (Mao et al., 1999), ACZL (Akagi et al., 1997) and R26RLacZ (Soriano, 
1999) for LacZ detection and RA/EG (Constien et al., 2001) and R26REYFP 
(Srinivas et al., 2001) for the detection of EYFP+ve cells. To this end, applying a dose 
of 2.5mg of tamoxifen for three consecutive days resulted in maximal detection of 
active and nuclear Cre-recombinase in K14CreER(G)T2 (Fig 18C). R26RLacZ or 
R26REYFP Cre-reporter were utilised for further lineage tracing experiments, since 
these strains showed the most specific LacZ or EYFP signal. As expected, EYFP (Fig  
18E) or LacZ (Fig 18F) of induced K14CreER(G)T2 mice could be detected in the 
IFE, the ORS of the entire HF and periphery of the SG at day 3 following tamoxifen 
treatment. Vehicle controls (oil) remained negative for LacZ (Fig 18G) or EYFP and 
Cre recombinase was expressed in a diffuse cytoplasmic fashion (Fig 18D).  
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Fig 18: Optimisation of tamoxifen application procedure and detection methods 
(A, B) K14CreER(G)T2 crossed to Cre-reporter mice were treated with tamoxifen (Tam) 
during resting phase of the hair cycle (telogen) to target all basal cells of the epidermis. 
Specific detection of nuclear Cre recombinase (C), EYFP (E) and LacZ (F) in the IFE, ORS of 
the HF and SG at 3 days of chase. Genotype-matched vehicle treated control mice showed a 
diffuse cytoplasmic localisation of Cre recombinase (D) and no LacZ signal (G) was detected. 
Scale bars represent 80µm.  
3.2.4.2 Identification of two specific K15CreER(G)T2 founder lines 
Following optimisation of the tamoxifen treatment and the detection methods for 
EYFP, LacZ and Cre, all K15CreER(G)T2 founder lines were subjected for further 
analyses (Fig 19). K15CreER(G)T2 (founder lines A-E and G; F,H were infertile) were 
crossed to R26RLacZ or EYFP Cre-reporter mice and Cre-recombinase was induced 
during quiescent state of the hair cycle (beginning of 2nd telogen, PD53) (Fig 19A). 
For each founder line different dose and duration of tamoxifen treatments were 
assayed to ensure the maximal labelling efficiency and specificity. Nuclear Cre, LacZ 
or EYFP signal was monitored in epidermal whole-mounts and back skin sections 
day 1 to 5 following Cre activation (minimum 3 mice/tracing time point). Localisation 
and number of labelled bulge cells of each of the K15CreER(G)T2 founder line was 
examined as summarised in Table 7. Mice of B_D_G_K15CreER(G)T2 founder lines 
showed a broad expression of Cre recombinase and reporter gene activation. These 
lines were not suitable for further investigations of HFSC function in tissue 
regeneration. E_K15CreER(G)T2 mice showed a moderate and exclusive labelling in 
the bulge region (5-10 cells), but unfortunately exhibited unspecific background 
activity in the vehicle controls.  
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Table 7: Analysis of Cre expression, number of labelled cells and    
intensity of Cre-reporter gene activation in K15CreER(G)T2/Cre 
reporter mice 
 
founder_line   n= 
bulge 
specifity 
amount of labelled 
bulge cells intensity 
A TAM 30 high low 1-4 high 
  Ctrl 22 % % % 
B TAM 5 low low  low  
  Ctrl 4 % % % 
D TAM 5 low low  low  
  Ctrl 3 % % % 
G TAM 5 low low  low  
  Ctrl 3 % % % 
C TAM 44 high high 20-40 high 
  Ctrl 21 % % % 
E TAM 9 low moderate 5-10 high 
  Ctrl 5 low moderate 5-10 high 
 
Eventually, two specific founder lines were identified (referred to as A_and C_line) 
which differed in the number of labelled bulge cells:  
i. Almost the entire HF bulge of tamoxifen treated C_K15CreER(G)T2 
R26RLacZ  mice comprised nuclear Cre (Fig 19C) and LacZ (Fig 19E) 
positive cell populations. Vehicle (oil) treated genotype-matched 
littermate controls remained negative for LacZ (Fig 19F) or EYFP (data 
not shown) and Cre recombinase was expressed in a diffuse 
cytoplasmatic fashion (Fig 19D). These data are in line with previous 
observations that the K15 promotor fragment targets the entire HF 
bulge (Morris et al., 2004). Thus, this high expressing 
C_K15CreER(G)T2 line could be utilised to genetically manipulate the 
entire HFSC compartment.  
ii. In contrast, individual bulge cells could be targeted using the low-
expressing A_line (Fig 19G-J). Single LacZ (Fig 19J), EYFP (Fig 19H) 
and nuclear Cre (2-5 +ve cells, Fig 19A) could be targeted at early time 
points (day 1-3) after tamoxifen treatment. In addition, single EYFP/Cre 
double positive cells could be detected the bulge region (Fig 19I), 
whereas the vehicle controls remained negative for EYFP or LacZ (Fig 
19K). Therefore, the A_K15CreER(G)T2 line provides an powerful tool 
to map the fate of single bulge-derived progeny.  
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Fig 19: Targeting of bulge cells using K15CreER(G)T2  
K15CreER(G)T2/R26RLacZ/EYFP mice were treated with tamoxifen during resting phase of 
the hair cycle (telogen, T) (A, B). Specific detection of bulge cells (B) in tamoxifen-treated 
K15CreER(G)T2 (Founder C and A) was demonstrated by nuclear Cre LacZ or EYFP 
stainings. Note that in C_K15CreER(G)T2 almost the entire bulge region was stained (C,E), 
whereas in the A_K15CreER(G)T2 line, individual bulge cells were targeted (G-J arrows). 
Vehicle controls (Ctrl) were always negative for LacZ (F,K) or nuclear Cre signal (D). Scale 
bars represent 80 µm. 
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3.3 Characterisation of targeted bulge SC 
3.3.1 Genetically labelled cells co-localise with SC markers of the    
 HFSC compartment 
To examine if the genetically labelled cells of K15CreER(G)T2-mice were indeed 
localised to the HFSC compartment, co-immunofluorescent studies of labelled 
keratinocytes with established HFSC/progenitor markers were conducted (Fig 20A). 
Cre recombinase of A_K15CreER(G)T2/R26REYFP mice was activated during 
resting phase of the hair cycle (telogen, PD53), where HFSC are thought to be 
quiescent. Initially, day 1-2 after tamoxifen treatment, labelled cells co-localised with 
established HF bulge markers such as K15, LRC and exhibited a high Itga6 
expression (Fig 20B-D), demonstrating that labelled cells were confined to the HFSC 
compartment. 
 
 
Fig 20: Genetically targeted cells co-localise with establised HFSC/progenitor markers 
Tamoxifen was applied to A_K15CreER(G)T2/EYFP mice during telogen. Co-
immunofluorescent studies of EYFP and bulge markers (A) were carried out 3 days following 
Cre activation. (B) Single EYFP+ve cells (arrow) co-localised with K15. (C) Labelled cells co-
expressed a high Itga6 signal. (D) Individual EYFP+ve keratinocytes were LRC (arrows). 
EYFP was not detected in vehicle (oil) treated littermate controls (E). Scale bar represents 
50µm.  
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3.3.2 Multipotency of targeted HFSC  
Next, we tested whether the labelled bulge cells were multipotent in vivo.  
To date, it is well established that HF regeneration requires a cyclic activation of 
HFSC in late telogen. This mechanism involves an activation and a mobilisation of 
HFSC before proliferation is induced to sustain hair growth (anagen phase) (Greco et 
al., 2009; Legue et al., 2010; Zhang et al., 2009). Applying tamoxifen to 
A_K15CreER(G)T2 mice during this HFSC activation phase (telogen to anagen 
transition, Fig 21A), a trail of single K15-derived progeny was detected along the 
forming HF (Fig 21C,E) (day 3 after Cre activation). Analysing anagen HF by 6 days 
of chase, the newly regenerated HF comprised K15-derived progeny and EYFP 
signal was frequently found in all different hair lineages including layers of the IRS 
(Fig 21G), the hair matrix (Fig 21G), the bulb and the precortex (Fig 21H). These 
findings were consistent with previous reports (Morris et al., 2004), demonstrating 
that targeted cells were multipotent and competent to sustain hair growth.  
In comparison to the tracing analyses performed in telogen, tamoxifen treatment 
during telogen to anagen transition resulted in an increased number of labelled cells 
at day 3 following Cre activation. An enhanced mobilisation of targeted cells and 
elevated cellular turn-over at this time point of the hair cycle might be a possible 
reason for this finding.  
To analyse whether targeted cells were long-living SC, lineage tracing analyses were 
performed following the next hair cycle (day 28 of chase). These experiments 
revealed that labelled bulge cells still contributed to HF regeneration, but were also 
detected exclusively in the HFSC compartment (Fig 21D). This data clearly show that 
no exhaustion of genetically marked bulge cells took place within one month of 
tracing. 
Taken together, these results imply that the genetically targeted K15+ve cells were 
indeed multipotent in vivo and will therefore be termed HFSC and all descending cell 
lineages will be defined as HFSC-derived progeny in the following experiments.  
Pilot studies were performed to test the proliferative capactity of labelled 
HFSC compared to K14+ve cells in vitro. First, epithelial character of primary 
keratinocytes derived from adult back skin was confirmed. The isolated cells were 
positive for K14, Itga6 and K17 and a minority was CD34 or K15+ve as verified by 
immunofluorescent stainings or FACS analyses (data not shown). Furthermore, 2500 
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initially seeded keratinocytes (passage 2) were competent to form large colonies 
(holoclones) by 2 weeks of cultivation (data not shown) indicating that a certain 
number of SC was present within the isolated keratinocyte pool. In a second set of 
experiments, C_K15CreER(G)T2 (high expressing line) and K14CreER(G)T2 mice 
crossed to LacZ-Cre-reporter mice were treated with tamoxifen at early telogen 
(PD53) and primary keratinocytes were isolated day 3 following Cre-activation. Cells 
of the 3rd passage were analysed for LacZ expression (Fig 21K,L). Interestingly, 
almost all K15CreER(G)T2-derived keratinocytes were positive for reporter gene 
activation, whereas only a minority of K14CreER(G)T2 cells expressed LacZ. These 
initial experiments suggest that K15-derived keratinocytes exhibited a growth 
advantage compared to K14CreER(G)T2-derived keratinocytes, indicating an 
increased proliferative potential in vitro. 
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Fig 21 Targeted bulge cells are capable to regenerate all hair lineages 
(A) Cre recombinase of A_K15CreER(G)T2 mice was activated during telogen to anagen 
transition. (B) Single EYFP+ve cells appeared in the bulge region at day 1 following Cre 
activation. Bulge-derived progeny was detected along the developing HF(C) and at all 
different hair lineages including ORS (E,F), IRS, matrix (Mx) (G), bulb (Bb) and precortex 
(Pc) (H) at 6 days of chase (n=3mice). Vehicle controls were negative for EYFP (J). Tracing 
labelled cells for 28 days, EYFP+ve keratinocytes were found almost at the entire HF. Note 
single cells in the bulge (D). Primary keratinocytes derived from K14CreER(G)T2/ or 
C_K15CreER(G)T2/ R26RLacZ skin (isolated at day 3 following tamoxifen treatment) were 
cultivated for 3 passages. Fixed cells were analysed for LacZ expression (K,L). Scale bars in 
B-J represent 80µm, in L 100 µm.  
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3.3.3 HFSC-derived progeny drives SG regeneration during resting 
 phase of the hair cycle 
To follow the fate of HFSC-derived progeny during telogen phase (quiescent state of 
the hair cycle) on a single cell level, we conducted lineage tracing experiments 
utilising the low-expressing A_line. Therefore, A_K15CreER/R26EYFP mice were 
treated with tamoxifen (2.5 mg) for 3 consecutive days and skin was analysed for 
EYFP expression at different time points (Fig 22). In an alternative experimental set-
up, a high dose of tamoxifen (4 mg) was applied once. The number of labelled HF of 
a minimum of 400 analysed pilosebaceous units (n=9 mice) was higher than 50 %.  
Initially, single labelled HFSC were present in the bulge within 1 to 2 days of chase 
(Fig 22B). Analysing day 3-5 following Cre activation, genetically targeted cells were 
also located at the UI and SD (Fig 22C) and HFSC-derived progeny repopulated the 
lower tip of the SG (Fig 22D). By 7 days of chase, almost the entire SG comprised 
EYFP+ve keratinocytes, implying a contribution of SC from the HF compartment to 
SG regeneration (Fig 22E,F). The interesting observation that only one of the two SG 
compassed EYFP+ve signal in a high frequency suggests that activation of more than 
one HFSC is required to renew both SG. 
From these experiments we conclude that single labelled HFSC were capable 
to replenish the SG within 7 days. SG homeostasis is a rather highly dynamic 
process in contrast to the cyclic HF regeneration, which renews in a time frame of 2 
weeks.  
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Fig 22 Commitment of bulge-derived progeny to sebaceous lineage 
(A) Lineage tracing experiments were performed during telogen phase using 
A_K15CreER(G)T2/R26REYFP mice. (B) Day 1-3 after Cre induction, single EYFP+ve cells 
were localised to the HF bulge. Day 3-5 labelled cells were observed at the UI (C, arrow) and 
the SD (D, arrow), resulting in the detection of EYFP+ve cells at the lower tip of the SG (D, 
arrow). Almost the entire SG was positve for EYFP by 7 days of chase (E,F). No specific 
signal was observed in vehicle controls (ctrl) (G). Scale bars represent 50µm. Statistical 
analyses of K15-traced cells were performed using A_K15CreER(G)T2/R26RLacZ 
transgenic mice. LacZ+ve cells within the pilosebaceous units (n=3 (d3, d5), n=2 d7 
mice/time point) were counted and grouped according to their expression in the bulge only, 
SD and SG (SD+SG) and a more complex pattern including bulge, SD and SG. S.D. of 3 
independent experiments per time point was calculated (H). 
 
Similar results were obtained using a LacZ-Cre-reporter line (data not shown) and no 
LacZ or EYFP signal was observed in vehicle (oil)-treated littermate controls (Fig 
22G). To determine the distribution of labelled cells in more detail, statistical analyses 
using A_K15CreER/R26RLacZ mice were carried out (Fig 22H, together with 
Andreas Kraus, Niemann Lab). Day 3 following Cre activation, the majority (73 %) of 
labelled cells were confined to an exclusive localisation in the bulge (bulge only 
pattern), whereas 7 % of the analysed pilosebaceous units showed a more complex 
pattern labelled in bulge, SD and SG. 20 % of labelled cells were detected in the SD 
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and SG, most likely because HFSC-derived progeny had already left the HFSC 
niche. Analysing day 5 and 7 following tamoxifen treatment, a dramatic decrease of 
cells being exclusively labelled in the bulge is observed (17 % day 5; 4 % day 7, 
respectively). Concominant with this finding, the percentage of pilosebaceous units 
labelled in the B, SD and SG is elevated (18 % day 5; 48 % day 7). Additionally, more 
LacZ+ve keratinocytes are located exclusively in SD+SG (65 % day 5; 49 % day 7). 
Taken together, the statistical analyses revealed that HFSC-derived progeny 
indeed exit the HFSC niche to drive SG renewal. Additionally, few labelled cells 
remained in the bulge, indicating that they might get mobilised at a later time point or 
were involved in the renewal of the HFSC pool itself.  
3.4 Renewal of the SG is a continuous process 
On the bases of these results, we addressed the question whether the process of SG 
regeneration by HFSC was linked to distinct phases of the periodic HF regeneration.  
Therefore, HFSC and their progeny labelled during HFSC mobilisation phase 
(telogen to anagen transition) were screened for reporter gene activation at sites of 
the SG. 3 days following Cre activation, SG were heavily repopulated by EYFP+ve 
keratinocytes, implying that the SG is renewed (Fig 23B). Analysing day 28 following 
Cre activation, single labelled cells appeared at the lower tips of the SG. In addition, 
no increase in the number of EYFP+ve cells at the SG was detected, indicating that 
our observations did not result from activation of progenitor cells resining within the 
SG (Fig 23D).  
As expected, HFSC-derived progeny was mobilised for HF renewal during telogen to 
anagen transition, but intriguingly, EYFP+ve keratinocytes were detected in clusters 
emanating from the JZ towards the IFE (Fig 23B). These clones did not persist after a 
tracing period of 28 days and no increase of EYFP signal in the IFE was observed. 
Interestingly, the contribution of HFSC-derived progeny to IFE renewal was 
enhanced compared to telogen tracing experiment. 
Next, we labelled HFSC at the beginning of anagen when activation of bulge SC for 
HF growth had completed (Fig 23F). Starting with single LacZ+ve cells in the bulge 
region at day 1 (Fig 23G), individually labelled keratinocytes appeared at the lower tip 
of the SG 3 days following Cre induction (Fig 23H). This culminated in the entire SG 
(SCD1+ve) being positive for activated Cre-reporter gene at day 5-7 of chase (Fig 
23I). In this set of experiments, no contribution of genetically labelled cells to HF 
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regeneration was observed as activation of HFSC had occurred earlier and vehicle 
treated control mice remained negative for reporter gene activation (Fig 23J).  
From this fate mapping studies we have learned that the process of SG 
renewal was not connected to the cyclic activation of HFSC for HF renewal, but 
rather occurred continuously. Furthermore, genetically targeted HFSC were 
competent to regenerate all epidermal lineages including the HF, SG and the IFE. 
 
Fig 23: Epidermal regeneration during different stages of the hair cycle 
(A) Fate mapping studies of HFSC-derrived progeny labelled at telogen to anagen transition 
(n=2-3 mice/time point). (B,C) HFSC-derived progeny contributed to HF regeneration. 
EYFP+ve keratinocytes were also detected at the SG, the JZ, the INF and the IFE. (D) 
Tracing HFSC-derived cells for 28 days, single EYFP+ve cells appeared in the SG (arrows). 
In vehicle treated double transgenic mice no reporter gene activation was found (E,J). (F) 
Lineage tracing experiments were conducted during anagen phase. Single LacZ+ve cells 
were confined to the bulge at day 1 (G,arrowheads). Day 3 following Cre activation, EYFP+ve 
progeny could be detected at the lower tip (H, arrows). EYFP+ve cells co-localised with the 
sebocyte marker SCD1 at day 5 after tamoxifen treatment (I). Scale bars represent 50µm. 
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3.5 Regeneration of the HFSC compartment and the SG in 
long-term studies 
To investigate if labelled HFSC were competent to replenish the pilosebaceous unit 
over a long period of time, we activated Cre-recombinase of A_K15CreER(G)T2/ 
R26RLacZ mice during 2nd telogen and traced HFSC-derived progeny for 6months. 
Analyses of LacZ+ve keratinocytes in epidermal tail whole-mounts revealed that the 
SG were still repopulated. Similar to the short-term tracing, one of the two SG 
showed an intense β-galactosidase activity (Fig 24B-D). These data exclude the 
possibility that HFSC-derived progeny resided within the SG and sustain SG 
homeostasis, since the number of labelled cells at sites of SG did not increase.  
Besides the SG, LacZ+ve cells were detected at the HFs including all hair lineages 
(Fig 24E-G) and hair fibres (Fig 24E-G asterisk). Additionally, the HF bulge itself 
contained an elevated pool of LacZ+ve keratinocytes (Fig 24B,C,J, 3 fold) compared 
to the number of initially labelled HFSC (day 3 following Cre activation).  
These data strongly imply that genetically targeted bulge cells were capable to 
regenerate the entire pilosebaceous unit and to replenish the HFSC compartment 
even after a time period of 6 months. The renewal of the SC pool seems to involve a 
symmetric cell division of the targeted HFSC. Control mice treated with vehicle alone 
never showed a specific LacZ+ve signal even after a time period of 6 months, albeit a 
slight crystrallic residue derived from the dye was observed attached to the HS.  
To examine the distribution of HFSC-derived progeny after 180 days of tracing (n=3 
mice) closer, statistical analyses were carried out (together with Andreas Kraus, 
Niemann Lab). Intriguingly, 53% of labelled pilosebaceous units consist of LacZ+ve 
keratinocytes localised to the bulge region, 32 % showed a more complex pattern, 
namely bulge, SD and SG and 15 % were exclusively labelled in the SD+SG (Fig 
24I). The increased number and localisation of Lacz+ve keratinocytes in the HF bulge 
indicates that targeted HFSC resided in the HF bulge.  
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Fig 24: Labelled bulge-derived progeny is competent to regenerate all epidermal 
compartments after 6 months of tracing 
(A) Long term analysis of bulge derived progeny labelled during 2nd telogen and LacZ+ve 
cells were traced following 180 days (n=3 A_K15CreER(G)T2/ R26RLacZ mice). The HFSC 
niche (B) and the SG were replenished (B,C,D). Bulge-derived progeny contributed to all hair 
lineages. Note that hair fibers (asteriks) were LacZ+ve (D,E,F). Vehicle treated contol mice 
showed no specific LacZ signal (H). (I,J) Statistical analyses to quantify the distribution of 
LacZ+ve cells at d180 (n=3mice, 178 analysed telogen HF). Counted cells were grouped 
concerning their expression in bulge only, SG+SD and B, SD+SG. S.D. was calculated. The 
number of labelled bulge cells per pilosebaceous unit at d3 and d180 following Cre activation 
was determined; p-value-0.018. Scale bars represent 50µm.  
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3.6 Transition of bulge-derived progeny through different 
 epidermal progenitor niches 
Multiple SC/progenitor compartments residing between the HFSC niche and the 
follicular infundibulum have been identified recently (Horsley et al., 2006; Jensen et 
al., 2009; Jensen et al., 2008; Nijhof et al., 2006; Snippert et al., 2010). 
To date, it is still unknown whether these different populations act autonomously or 
are integrated into a hierarchy. What is the functional relevance of these different SC 
and progenitor cell populations?  
Since our results clearly demonstrated that SC-derived progeny from the HF niche 
migrated upwards the HF to renew the SG, we next aimed to investigate whether 
labelled HFSC were interconnected with these different SC/progenitor reservoirs 
thereby creating a hierarchy.  
Therefore, EYFP+ve cells were analysed for the expression of epidermal 
SC/progenitor markers during a time frame of 7 days of tracing (Fig 25A,D,H,L).  
As expected, a co-localisation of single symmetrically grouped LRC with EYFP was 
observed in the HF bulge. Additionally, double positive keratinocytes were detected 
at the UI at 5 days following Cre activation (Fig 25B). The BrdU-label was diluted 
towards the SG and the INF supporting our initial finding that HFSC-derived progeny 
was indeed capable to regenerate the SG. 
At early tracing time points (day 3 post labelling), genetically labelled EYFP+ve cells 
were negative for MTS24 antigen (Fig 25E) and Lrig1 (Fig 25I), which both mark 
progenitor cells at the periphery of the SG and at the UI (MTS24, Nijhof et al., 2006) 
and the JZ (Lrig1, Jensen et al., 2009) (Fig 25D,H). Concomitantly with the observed 
migration of HFSC-derived progeny towards the SG during tracing (day 5-7), a 
change in marker expression in EYFP+ve keratinocytes was seen. Notably, a minority 
of genetically labelled cells remained to be positive for bulge markers K15 and 
Itga6high (data not shown). Instead, HFSC-derived progeny was detected at the 
MTS24+ve UI by 5 days following tamoxifen treatment and co-localised with MTS24 
antigen at the perimeter of the SG (Fig 25F). In addition, some labelled cells that 
localised at the SD and inner periphery of the SG co-expressed Lrig1 (Fig 25J, higher 
magnification in K). Interestingly, the images suggested that Lrig1 marked the trail of 
HFSC-derived progeny to the lower tip of the SG. By 5 days of tracing, EYFP+ve 
keratinocytes at the lower tip of the SG co-localised with SCD1 (Fig 25N), a marker 
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for mature sebocytes (Sampath et al., 2009). This co-localisation comprised almost 
the entire SG 7 days following Cre activation (Fig 25O), showing that HFSC-derived 
progeny differentiated towards sebocyte lineage.  
 Taken together, these experiments indicate that targeted HFSC gave rise to 
MTS24 antigen and Lrig1+ve progenitor populations indicating a hierarchy of HFSC 
and MTS24 antigen and Lrig1 +ve progeny. 
 
 
Fig 25: Traced bulge-derived cells co-express different progenitor markers  
along their trail to the SG 
Co-immunofluorescent studies of EYFP+ve keratinocytes of activated A_K15CreER(G)T2/ 
R26REYFP-mice and different SC/progenitor markers (A,D,H,L) were performed using 
telogen whole-mounts. 3 days following Cre activation, no EYFP signal was detected in the 
MTS24 (E), Lrig1 (I) and SCD1 (M) positive cells. EYFP and LRC double positive cells were 
detected at the HF bulge and the UI at 5 days of chase (B). The label was also diluted along 
the UI in vehicle treated controls, which were negative for EYFP (C). Day 5 following Cre 
activation HFSC-derived progeny is detected in the MTS24 antigen (F) and Lrig1 (J,K) 
positive compartment. Single EYFP+ve cells located at the lower tip of the SG co-expressed 
SCD1 (N) culminating in almost the entire SG to be double positive at 7 days of chase (O). 
Scale bars represent 50 µm. 
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3.7 HFSC-derived progeny expresses marker molecules for 
 sebaceous lineage commitment  
Next, we validated whether sebaceous commitment of HFSC-derived progeny was 
also reflected on a transcriptional level. Therefore, FACS sortings were performed 
utilising freshly isolated keratinocytes from induced A_K15CreER(G)T2/R26REYFP 
telogen back skin (together with Heike Brylka, Niemann lab). Bulge-derived 
keratinocytes were enriched by sorting for EYFP/Itga6high or CD34/Itga6high at day 2 
following Cre activation (Fig 26A-C). To purify SG-associated cells by 6 days of 
chase, EYFP/Lrig1 or Lrig1/Itga6high +ve populations were sorted (Fig 26D-F).  
Subsequently, RNA was isolated from these different populations and used for cDNA 
synthesis. Expression of SG-associated genes such as Lgr6, Blimp1 and SCD1 was 
determined using qRT-PCR (Fig 26G). Fold regulation was adapted to 18S 
expression and normalised to Itga6+ve keratinocytes. Comparing bulge-derived 
(EYFP/Itga6high and CD34/Itga6high) and SG-derived (EYFP/Lrig1 and Itga6 high/Lrig1) 
keratinocytes revealed no major differences in Lgr6 expression levels, suggesting 
that Lgr6+ve SC pool is most likely located in between the bulge-and the SG-sorted 
populations.  
Furthermore, the expression of Blimp1, a proposed marker for unipotent progenitors 
detected close to the SD (Horsley et al., 2006), was up-regulated in EYFP/Lrig1 and 
Itga6 high/Lrig1+ve cell populations (7 fold and 12 fold, respectively) when compared to 
the basal cell pool. The most tremendous change (55 fold) was seen for the sebocyte 
marker SCD1. Notably, EYFP/Itga6high and CD34/Itga6high sorted populations shared 
almost the same expression levels of the analysed marker. As expected, the 
expressional changes of EYFP/Lrig1 and Itga6 high /Lrig1 isolated keratinocytes were 
quite similar.  
Thus, sebaceous commitment of HFSC-derived progeny observed in the 
lineage tracing experiments was also confirmed on the molecular level. 
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Fig 26: HFSC derived progeny at the periphery of the SG expressed markers for 
sebaceous lineage  
A_K15CreER(G)T2/R26REYFP mice were treated with tamoxifen during 2nd telogen phase 
(2 independent experiments). Primary keratinocytes were isolated and FACS-sorting (n=2 
mice/sort) was performed to enrich keratinocytes from the bulge region (2 days of tracing, A) 
and from the JZ and SG (6 days of tracing, D).To isolate bulge cells keratinocytes were 
stained using either the combination of YFP/Itga6high (B) or CD34/Itga6high (C). To purify 
bulge-derived progeny located at the periphery of the SG, YFP/Lrig1+ve (E) and 
Itga6high/Lrig1+ve (F) cells were sorted. qRT-PCR analysis of indicated SG-associated genes 
was performed using cDNA derived from the different populations (G). Expression levels 
were normalised to 18S expression and are depicted as fold regulation compared to Itga6 
signal. S.D. was calculated. 
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3.8 Ectopic SG formation is driven by HFSC 
Lef1 and ß-catenin signalling is crucial for cell fate determination in various epithelial 
tissues. In the skin, impaired Lef1 signalling promotes sebaceous fate decision 
(Merrill et al., 2001; Niemann et al., 2002). It has been demonstrated that epidermal 
expression of dominant negative Lef1 (K14ΔNLef1) drives the synthesis of ectopic 
SG (nSG) along deformed HF (Fig 27B,C). Additionally, SG are enlarged. These 
findings provoked the question whether formation of these ectopic SG originated from 
an unbalanced fate decision of HFSC.  
3.8.1 Expression of SC and progenitor markers in K14ΔNLef1 mice 
In a first set of experiments, the localisation and expression levels of HFSC and 
progenitor markers in K14ΔNLef1 epidermis were determined conducting immuno-
staining and qRT-PCR. In comparison to wt epidermal whole-mounts (Fig 27A), K15 
and CD34 protein were confined to a deformed bulge region which was reduced in 
size (Fig 27B,C). This was consistent with the molecular expression patterns 
validated by qRT-PCR (together with Peter Schettina, Niemann lab). RNA isolation 
from freshly isolated keratinocytes of wt and K14ΔNLef1-mice was followed by cDNA 
synthesis. Gene expression was analysed. The results were adopted to GapDH 
expression and are depicted as fold change compared to wt. A dramatic decrease of 
60% in K15 expression could be detected in keratinocytes from K14ΔNLef1 mice, 
whereas CD34, Sox9, Itga6-levels were only slightly reduced. Notably, NFATc1, 
which is involved in the regulation of SC quiescence, was down-regulated to 20 % 
(Fig 27D). This suggests that the pool of quiescent HFSC was decreased in 
K14ΔNLef1 mice. Furthermore, the expression levels of SG-associated genes were 
determined (Fig 27E): Keratin6a (K6a) which is strongly expressed at the SD (Gu and 
Coulombe, 2008) was more than 5 times up-regulated in K14ΔNLef1-derived 
keratinocytes. Expression of TenascinC -known to be up-regulated in 
MTS24antigen/Plet1+ve progenitors (Nijhof et al., 2006)- was also elevated. 
Importantly, one of the key regulators determining sebaceous fate decision, c-myc 
and its target Nucleolin were dramatically down-regulated in K14ΔNLef1 epidermis 
compared to control littermates. This implicates a possible independent regulation of 
sebaceous differentiation by Lef1 and c-myc.  
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Fig 27: Epidermal SC and SG-associated markers are differentially expressed in 
K14ΔNLef1 mice. 
To investigate the localisation and expression of SC and progenitor marker in K14ΔNLef1 tail 
epidermis, immunostainings were performed analysing the indicated proteins. (A) K15 
protein was expressed in wt HF bulge. (B,C) K15 protein and CD34 marked the deformed HF 
of K14ΔNLef1 epidermis. (D,E) SC and SG associated marker molecules were analysed on a 
transcriptional level. qRT-PCR was conducted and fold differences between K14ΔNLef1 and 
wt (n=3mice) were adjusted to GapDH expression and are depicted as fold regulation 
compared to wt expression. S.D. was calculated.  
 
3.9 Bulge-derived progeny is involved in ectopic SG 
 formation 
To examine whether HFSC contributed to ectopic SG development in K14ΔNLef1, 
we performed lineage tracing experiments using A_K15CreER(G)T2/EYFP mice 
crossed into the K14ΔNLef1 background (Fig 28A). Cre recombinase was activated 
at early telogen. By 3 days of chase, a cluster of EYFP+ve cells was confined to the 
deformed bulges (Fig 28B). At this early time-point of labelling, no co-localisation with 
SCD1, a marker for mature sebocytes, was observed. Intriguingly, HFSC-derived 
progeny migrated towards ectopically generated SG by 5 days of tracing. In 
particular, SCD1 and EYFP co-expression was not only restricted to the enlarged 
upper SG, but also co-localised to the de novo formed SG (Fig 28C,D).  
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Fig 28: Bulge-derived progeny contributes to ectopic SG formation in K14ΔNLef1 
mice. 
(A) Lineage tracing experiment of K15CreER(G)T2/K14ΔNLef1/R26REYFP mice (n=3 
animals/time point) during 2nd telogen. Co-immunofluorescent studies of EYFP and SCD1 
were performed. A cluster of EYFP+ve keratinocytes was detected in the deformed HF bulge 
at day 3 after Cre activation and labelled bulge cells were negative for SCD1 (B). By 5 days 
of tracing, bulge-derived progeny was found at the ectopic SG (nSG) (arrows) and 
coexpressed SCD1(C and higher magnification in D). (E) Single EYFP+ve cells were resident 
in the bulge region after a tracing period of 36 days (n=2) and clonal expansion of bulge-
derived progeny were seen in some of the deformed HF (F). No EYFP signal was seen in 
vehicle controls (G). Scale bars represent 50 µm. 
 
These observations demonstrate that HFSC-derived progeny contribute to 
development of ectopic SG in K14ΔNLef1 mice. To test if targeted HFSC reside in 
the bulge region of K14ΔNLef1 mice, we performed long-term tracing experiments. 
36 days (Fig 28E-G) and 90 days (data not shown) following Cre activation, two 
different staining patterns were observed. First, small aggregates of EYFP+ve cells 
were localised to the deformed bulge region (Fig 28E, arrowheads). Alternatively, 
large cluster of HFSC-derived progeny were distributed along the deformed 
pilosebaceous units including the ectopic SG (Fig 28F). Epidermal whole-mounts 
derived from vehicle control mice did not show a specific EYFP signal (Fig 28G). 
 These data imply that the HFSC pool of K14ΔNLef1 mice was not exhausted 
over time.  
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3.10 Development of ectopic SG is accompanied by the 
 establishment of new progenitor niches 
The formation of ectopic SG by HFSC-derived progeny raised the interesting 
question how the SG-associated progenitor markers MTS24 antigen and Lrig1 were 
expressed in K14ΔNLef1 mice. Therefore, immunofluorescent studies were carried 
out analysing these markers in epidermal whole-mounts derived from K14ΔNLef1 
mice. In addition to its localisation at the periphery of the enlarged SG and deformed 
JZ, Lrig1 was also detected at the perimeter of the newly generated SG (Fig 29B). 
The expression pattern of the UI-marker MTS24 was also altered in K14ΔNLef1 tail 
epidermis. Single cells appeared in close proximity to the deformed bulge and the 
most intense signal was observed at the branching ducts of the ectopic SG (Fig 29C). 
These data indicate that concomitantly with the development of ectopic SG new 
progenitor niches were established.  
Next, we analysed the relationship between labelled HFSC-derived progeny and SG-
associated progenitor markers in more detail conducting co-immunofluorescent 
studies on induced A_K15CreER(G)T2/K14ΔNLef1/R26REYFP-epidermis (n=5). 
Accessorily to the co-localisation of individual EYFP with MTS24 antigen and Lrig1 at 
sites of the upper SG, the majority of EYFP and MTS24 antigen double positive cells 
were found at the branching ducts of the de novo synthesised SG (Fig 29F). 
Interestingly, many Lrig1 and EYFP double positive cells were detected at the 
perimeter of the ectopic SG (Fig 29E). Analysing K15 protein at this stage of tracing 
revealed that HF with EYFP+ve labelled cells restricted to the bulge region still could 
be found. The majority of HF showed an EYFP+ve signal in the deformed HF, de 
novo SG and enlarged SG (Fig 29D), which were negative for K15 antigen.  
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Fig 29: Ectopic SG formation is accompanied with the establishment  
of de novo progenitor niches 
(A) MTS24 antibody recognises the UI and the periphery of the SG (SCD1+ve) in wt tail 
epidermis. (B,C). MTS24 antigen and Lrig1 were localised at the SG and ectopic SG (nSG) 
visualized by SCD1 staining in K14ΔNLef1 tail epidermis. (D-E) Co-immunofluorescent 
studies of SC/progenitor markers and EYFP+ve keratinocytes of activated 
A_K15CreER(G)T2/ K14ΔNLef1/ R26REYFP tail epidermis (n=5 mice). At 5 days of tracing a 
clustered EYFP-pattern detected in the deformed hair follicle bulges colocalised with K15 
protein (D, arrowheads). EYFP+ve keratinocytes co-localised with Lrig1 (E, arrowheads) and 
with MTS24 antigen (F, arrowheads) at the periphery of nSG. Scale bars represent 50 µm. 
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3.11 HFSC-derived progeny contributes to epidermal 
 tumourigenesis 
3.11.1  3D-visualization of epidermal tumours 
Repression of β-catenin mediated Lef1 signalling in the epidermis not only drives 
ectopic SG formation, impairs HF differentiation and stimulates transdifferentiation of 
keratinocytes (Niemann et al., 2002). Furthermore, early lesions develop which are 
characterised by large cysts attached to a cluster of abnormally differentiated cells 
(Fig 30A). Intriguingly, K14ΔNLef1-mice start to develop sebaceous adenomas and 
papillomas with sebocyte differentiation starting from 3 months of age. Early 
sebaceous adenomas appear as small lobules with a proliferative outer layer of 
keratinocytes (Fig 30B, dashed line) and an enhanced sebocyte (S) differentiation in 
the centres (Fig 30B). Fully developed sebaceous adenomas are characterised by 
large and complex organised tumour lobules comprising differentiated sebocytes 
surrounded by an undifferentiated basal layer (Fig 30C, dashed line). This 
proliferative layer is Keratin14 (K14) positive, whereas the differentiated sebocytes 
located at the center of tumour lobules express SCD1. Previous chemical 
carcinogenesis experiments have clearly shown that sebaceous tumourigenesis in 
K14∆NLef1 mice can be induced by a single application of a carcinogen (DMBA). 
DMBA treatment of K14∆NLef1 mice resulted in the development of macroscopically 
visible tumours within a time frame of 4 weeks (Niemann et al., 2007).  
Thus, this inducible K14ΔNLef1 model provides a powerful tool to study early steps of 
tumourigenesis and to investigate the origin and cause of tumour formation. Since 
bulge-derived progeny contributed to ectopic SG formation in K14∆NLef1 mice, an 
emerging issue was to investigate a function of HFSC-derived progeny in sebaceous 
adenoma formation within the K14∆NLef1 inducible tumour model.    
 To allow a 3D visualisation of single cells within early sebaceous lesions and 
sebaceous tumours of back skin, we set out to optimise the protocols for the isolation 
of epidermal whole-mounts derived from tumourigenic lesions. Therefore, K14∆NLef1 
mice were treated with DMBA at onset of 2nd telogen and whole-mounts were 
isolated at early (3 weeks) and late stages (6-8 weeks) post tumour initiation. 
Subsequently, different concentrations and incubation times for EDTA treatment were 
tested to isolate epidermal whole-mounts up to 0.8 cm diameter in size.  
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To investigate the morphology of these whole-mounts, immunofluorescent studies 
were carried out. As expected, K14 was detected along the early lesions (Fig 30D).  
Analysing later stages following tumour initiation, K14 expression was observed 
along the lobular structures (Fig 30E), whereas SCD1 marked cells within the centre 
of the lobules (Fig 30F). This organisation resembled the histology of early tumours 
seen in H/E stained cross-sections and therefore will be defined as sebaceous 
tumours in the following lineage tracing analyses. Taken together, the protocol to 
isolate whole-mounts was adapted to visualise early lesions and sebaceous tumours 
and now provides a powerful tool to visualise epidermal tumours in a 3D fashion 
 
Fig 30: Development of skin lesions and sebaceous adenomas in K14ΔNLef1-mice 
H/E stained cross sections of K14ΔNLef1-derived skin and tumours depicts an early lesion 
comprised of a large cyst attached to a cluster of abnormally differentiated cells (A) and an 
early sebaceous adenomas (SA) characterised by small lobules with differentiated sebocytes 
(S) in the center and a basal layer (dashed lines) at the periphery (B). Fully developed SA 
exhibit complex tumour lobules with sebocyte differentiation (S) surrounded by a basal layer 
(dashed line) (C). (D-E) K14 immunostaining of whole-mounts isolated from back skin of 
K14ΔNLef1 mice 3 weeks following DMBA-treatment (n=2 mice) visualising compact 
organised early lesions (D). K14 was expressed at the periphery of densely packed lobular 
structures derived from K14ΔNLef1-back whole-mounts 6 weeks after tumour initiation (n=3 
mice) (E). SCD1 marked more differentiated sebocytes (E). Note that these structures (E,F) 
resemble the lobular organisation of SA as observed in B. Scale bars represent 100 µm in A-
C and 50 µm in D-E. 
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3.11.2 Lineage tracing of different keratinocyte populations within 
 the K14∆NLef1-tumour model 
To optimise the application and detection protocols for lineage tracing analyses within 
the K14∆NLef1-tumour model, K14CreER(G)T2/R26RLacZ/K14∆NLef1 mice (n=6) 
were utilised as positive control to target keratinocytes from the entire basal layer (Fig 
31A) including the IFE, HF, SG and ectopic SG (Fig 31B). Therefore, tail and back 
skin of triple transgenic mice was treated with DMBA at onset of 2nd telogen. At day 3 
following tumour initiaion, a dose of 2.5 mg tamoxifen was applied daily for the 
following 3 days (Fig 31A). Epidermal whole-mounts derived from DMBA-treated tail 
skin were analysed for activated Cre recombinase and reporter gene expression at 
day 8 and 12 following DMBA treatment. As expected, nuclear active Cre and LacZ 
signal was monitored in the IFE, HF, SG and ectopic SG, indicating that the 
experimental set-up was sensitive enough for further fate mapping analyses (Fig 
31C,E). Genotype-matched littermate controls treated with DMBA and vehicle (oil) 
were negative for nuclear Cre or LacZ signal. In some cases, a background activity of 
LacZ was observed in the IFE and hair channel of acetone and DMBA- and oil 
treated K14CreER(G)T2/R26RLacZ/K14∆NLef1-epidermis (Fig 31F). In contrast, Cre 
recombinase in these controls was diffusely distributed in the cytoplasm, indicating 
that the seen LacZ signal was due to background from the LacZ staining procedure. 
To investigate whether the improved labelling protocols were suitable to trace 
descending cell lineages from almost the entire HFSC population within the 
K14ΔNLef1 tumour model, the high-expressing C_K15CreER(G)T2 strain was 
subjected to DMBA-treatment and the same application procedures as for the 
K14CreER(G)T2 mice were used. Analysing tail epidermis at day 10 following DMBA-
application revealed that the majority of LacZ+ve cells was confined to the upper SG 
and ectopic SG, whereas only few cells remained to be positive in the bulge. The 
most prominent LacZ signal was observed at the lower tips of the SG and ectopic SG 
(Fig 31H). 13 days following DMBA-treatment, LacZ+ve keratinocytes were 
distributed along the deformed pilosebaceous units (Fig 31I), resulting in detection of 
strong reporter gene activation in early skin lesions by 32 days following tumour 
initiation (Fig 31J,K). Analysing LRC and Cre expression of DMBA-treated epidermal 
whole-mounts showed that almost the entire bulge region was negative for nuclear 
Cre and LRC (Fig 31M), indicating that mobilisation of HFSC had occurred. Instead, 
nuclear Cre was localised to the SG, nSG and IFE and BrdU label was diluted 
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towards these compartments. Triple transgenic littermate controls treated with DMBA 
or acetone and vehicle (oil) were negative for nuclear Cre or LacZ signal (Fig 31L). 
 
Fig 31: Optimisation of the detection protocols for lineage tracing experiment during 
sebaceous tumour formation  
(A) Tumour formation was initiated and Cre recombinase in K14+ve (B) or K15+ve (H) cell 
populations was induced day 3 post DMBA treatment. Whole-mounts were analysed for Cre 
or LacZ expression. (C-F) Nuclear Cre in induced K14CreER(G)T2 mice was detected in the 
basal layer (C), whereas LacZ+ve keratinocytes were localised to the IFE and lower tip of the 
SG and nSG (E, arrows). LacZ stained vehicle controls occasionally showed a background in 
the IFE and HS (F), whereas Cre was diffusely distributed (D). (G-M) In activated 
C_K15CreER(G)T2 mice, LacZ+ve keratinocytes were found in SG and nSG and few positive 
cells were confined to the bulge 10 days following DMBA treatment (H, arrowhead). The 
deformed pilosebaceous unit including nSG (I, day 13) and sebaceous lesions (day 32, J,K) 
were LacZ+ve. HF bulge was almost negative for nuclear Cre or LRC, whereas SG and nSG 
were strongly +ve for Cre and LRC (day 32) (M, arrowheads). DMBA-and vehicle treated 
C_K15CreER(G)T2 epidermis was negative for LacZ (L). Scale bars in D, E, M 80µm, H,L 
50µm.  
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From these experiments we conclude that cell populations targeted by the 
high expressing C_K15CreER(G)T2 contributed to early skin lesions. The 
observation that only few LacZ+ve cells were detected in the bulge could be due to a 
fast mobilisation of bulge cells in response to DMBA treatment resulting in a high 
cellular turn-over. Since Cre recombinase was induced 3 days post DMBA-
application, it was restrictive to analyse very early time points. Performing lineage 
tracing analyses using the high expressing C_K15CreER(G)T2 strain did not allow 
fate mapping analyses of individual clones in tail epidermis. To circumvent this 
limitation, we decided to utilise the low expressing A_K15CreER(G)T2 mice for 
further tumour studies.           
In addition, we activated Cre recombinase at day1 following DMBA treatment to 
monitor the fate of HFSC-derived progeny immediately after tumour initiation. To 
reduce the background of LacZ signal observed in DMBA or acetone-treated 
K14CreER(G)T2/R26RLacZ/K14∆NLef1 mice, R26REYFP Cre reporter mice were 
utilised for further tracing analyses.  
3.11.3 HFSC-derived progeny drives sebaceous tumourigenesis 
Next, we aimed to examine if individual labelled HFSCs were indeed involved in the 
process of sebaceous tumourigenesis. Therefore, the low expressing 
A_K15CreER(G)T2/R26REYFP/K14∆NLef1 mice (n=12) were utilised for chemical 
carcinogenesis experiments and the fate of HFSC-derived progeny was monitored 
within a time frame of day 5 to day 42 following tumour initiation (Fig 32A,B). Large 
areas were screened for EYFP expression in whole-mounts derived from DMBA 
treated back and tail. Analysing early stages of tumour formation (day 5 following 
DMBA treatment), a clustered EYFP signal was restricted to the bulge region of tail 
epidermis (Fig 32C). Interestingly, the number of initially labelled cells was increased 
compared to acetone treated controls (data not shown), indicating an enhanced 
proliferation caused by DMBA treatment. Consistent with the data from the fate 
mapping analyses during the development of the K14∆NLef1 phenotype, HFSC-
derived progeny contributed to ectopic SG formation by 7days of chase (Fig 32D). 
During the process of sebaceous tumourigenesis (day 20 post DMBA-treatment), 
clonal expansion of EYFP+ve keratinocytes was detected along deformed HF (Fig 
32E,F). By 42 days of chase, HFSC-derived progeny was found in early lesions 
derived from back skin (Fig 32G,H), resulting in almost the entire sebaceous tumours 
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to comprise EYFP+ve cells (Fig 32K). Notably, at sites of early lesions and the tumour 
lobules, co-localisation of more differentiated SCD1+ve sebocytes and HFSC-derived 
progeny was observed (Fig 32J,L,M).  
 
Fig 32: Bulge-derived progeny contributes to sebaceous adenoma formation 
Lineage tracing experiments were conducted to map the fate of single HFSC-derived 
progeny within the inducible K14ΔNLef1 tumour model (A). Epidermal whole-mounts (tail, 
back, early lesions and tumours) were analysed for EYFP expression at different time points 
following tumour initiation (DMBA) and Cre induction (Tam) at d1 (B). Starting with a cluster 
of labelled cells confined to the bulge (C), HFSC-derived progeny was detected at sites of the 
ectopic SG (nSG) (D). Clonal expansion of EYFP positive cells was observed at day 20 
following Cre activation (E,F). By 42 days of chase, EYFP+ve cells were found in early 
lesions (G,H) and sebaceous tumours (J-M). YFP/SCD1+ve cells were visible in early lesions 
and in more differentiated parts of the sebaceous tumours (L, M, arrows). DMBA-treated 
vehicle controls displayed an autofluorescence, but were negative for EYFP (I,N). Scale bars 
represent 50 µm. 
 
To this end, 12 out of 14 analysed early sebaceous tumours derived from back skin 
(n=6 mice) and 6 out of 7 early sebaceous tumours isolated from tail epidermis 
exhibited EYFP+ve signal (Table 8). 
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   Table 8: Detection of EYFP+ve keratinocytes in early lesions  
   and sebaceous  tumours (n=6 mice) 
  early lesions sebaceous tumours 
    back epidermis tail epidermis 
TAM 3/4 12/14 6/7 
Ctrl 0/1 0/3 0/2 
Albeit whole-mounted sebaceous tumours (n=3 for back and 2 for tail whole-mounted 
tissue) isolated from DMBA-treated vehicle (oil) controls (n=2mice) exhibited an 
enhanced autofluorescence, no EYFP signal could be detected (Fig 32I,N). As 
expected, acetone-treated tamoxifen-induced A_K15CreER(G)T2/R26REYFP/ 
K14∆NLef1 controls never developed tumours and showed EYFP+ve keratinocytes at 
the bulge region but also at sites of the ectopic SG (by 20 or 42 days of chase). 
Taken together, these experiments clearly demonstrate that tHFSC-derived progeny 
contributed to tumourigenesis and was indeed committed to sebaceous lineage 
within the tumours. 
3.12 Manipulation of Lef1-signalling in the HFSC niche 
Spontaneous regeneration in tissue homeostasis requires a tightly regulated balance 
between SC quiescence and activation. Besides BMP, Notch and Hh, Wnt/β-catenin 
signalling is essential for epidermal regeneration (Blanpain and Fuchs, 2009). 
Various reports demonstrated that inhibited Wnt-signalling in the HFSC niche is 
important for SC quiescence, wheras stimulation of the pathway is thought to play a 
role in the activation of bulge SC for cyclic HF regeneration (Lowry et al., 2005; Lo 
Celso et al., 2004). At the base of the HF, within the precortex, an active β-
catenin/Lef1 transcriptional complex is crucial for HF differentiation (Andl et al., 
2002). Here, we aimed to manipulate Lef1 signalling in the HFSC niche in vivo and to 
study the consequences on epidermal regeneration and differentiation. An important 
issue was to investigate if the expression of mutated Lef1 in the HFSC compartment 
is sufficient to drive sebaceous tumourigenesis. Therefore, we have developed a 
transgenic mouse model expressing mutant Lef1 lacking the β-catenin binding 
domain under the control of a K15 promoter fragment (K15ΔNLef1 mice). 
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3.12.1 Generation of K15ΔNLef1 transgenic mice 
The 5 kb K15 promoter fragment derived from pK15CreER(G)T2 was used to target 
N-terminally deleted Lef1 to the HFSC compartment (Fig 33A). Therefore, a partial 
digestion of pK15CreER(G)T2 was performed to excise CreER(G)T2 thereby 
allowing the insertion of N-terminally deleted Lef1 (detailed decription of the clonig 
procedures in chapter 2.2.5.4). A myc-tag in front of ΔNLef1 enabled transgene 
detection.  
 
 
Fig 33: pK15ΔNLef1 was cloned and linearised for subsequent microinjection 
(A) ΔNLef1 lacking the β-catenin binding domain (BD) was cloned downstream of a 5 kb 
K15promotor fragment. A myc-tag of ΔNLef1 facilitates transgene detection.  
(B) Restriction map depicting pK15ΔNLef1. The plasmid was digested using NotI enzyme. A 
7 kb fragment of the linearised construct was purified for microinjection. A concentration of 5 
ng/µl of the purified construct was estimated by the comparing different amounts of the 
purified construct with different concentrations of a mass ruler (C).  
 
Having verified the right insertion and sequence of the construct, its functionality was 
tested in vitro. Keratinocytes were transfected with pK15ΔNLef1 and subsequently, 
immunofluorescent studies were performed to detect the myc-tag and transgene 
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expression. These experiments showed that 2% of the cells expressed the 
transgene, respectively (done by Gabriel Peinkofer, diploma student, Niemann lab, 
Peinkofer, 2008) demonstrating that pK15ΔNLef1 was functional in vitro. 
To generate K15ΔNLef1 transgenic mice, pK15ΔNLef1 was linearised using NotI 
enzyme and a 7 kb fragment was isolated and purified. Purity, quality and 
concentration were determined by agarose gel-electrophoresis and 
spectrophotometric analysis (Fig 33B,C).  
Subsequently, linearised and purified DNA [5ng/µl] was introduced into the 
pronucleus of fertilised oocytes (performed by the transgenic core facility at the CBG, 
Dresden). 300 oocytes were transplanted into different pseudo-pregnant foster 
animals. Genomic DNA (gDNA) was isolated from tail tissue derived from the 
offspring (n=47) and was used as template to amplify a fragment either within the 
ΔNLef1 sequence or a region between K15 promotor and the β-globin intronII. Three 
positive founder lines (referred to as A_B_C_line) were identified. The transgene 
could also be amplified using gDNA isolated from F1-generation showing germline 
transmission of the construct.  
To determine the copy number of inserted K15ΔNLef1, Southern-Blot analyses were 
employed using gDNA derived from F1-generation. Since a probe was designed 
recognizing ΔNLef1, gDNA derived from K14ΔNLef1-mice could be utilised as 
positive control. Chemiluminiscent intensity of Southern Blots probed with ΔNLef1 
was measured densiometrically (ImageJ, NIH). The values were adjusted to the 
intensity of Southern blots probed with IL2R (interleukin 2 receptor), which is 
integrated once into the murine genome (Carrol et al.,1995).  
These analyses revealed that the B_K15ΔNLef1 (n=7) showed the highest, 
C_K15ΔNLef1 (n=4) a moderate and A_K15ΔNLef1 (n=4) a low integration rate of 
the transgene. Notably, the copy number of B_K15ΔNLef1-mice constituted one third 
of the integration rate of mutant Lef1 in K14ΔNLef1 (Peinkofer, 2008 and Andreas 
Kraus, Niemann lab).  
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3.12.2 Impaired epidermal differentiation and tumour formation in 
 K15ΔNLef1-mice 
K15ΔNLef1mice were born healthy and showed a normal postnatal development. 
Interestingly, K15ΔNLef1 mice (F0-F2-generation, A_line n=10, B_line n=11, C_line 
n=7) commonly displayed a progressive but reversible hair loss relating to different 
areas of the body incipient with an age of 7-10 months, whereas age and sex-
matched wt controls showed a normal hair coat. The low expressing A_K15ΔNLef1 
line displayed the mildest phenotype, which might be due to a dose-dependent effect.  
Detailed histological and immunofluorescent analyses of epidermal whole-mounts 
and skin sections at different ages were carried out (by Heike Nöbel, diploma 
student, Niemann lab, Nöbel, 2009) to investigate whether morphogenesis and 
epidermal differentiation were affected in K15ΔNLef1 mice.  
Initial histological examination of skin sections derived from 2.5 months old 
K15ΔNLef1 mice (A_and C_line, n=4) showed a thickening of the IFE and a 
development of cysts. In addition, SGs were enlarged and HFs occasionally 
elongated.  
Further immunological characterisation of the IFE revealed an elevated expression 
level of several lineage markers for the IFE (such as K10 and Loricrin). 
Concomitantly, the expression of Ki67, a marker for cell proliferation, and K6, a 
marker for hyperproliferation in the IFE, were increased. These data suggest that the 
over-expression of mutant Lef1 in the HF bulge stimulates cell fate specification 
towards the IFE.  
Interestingly, SG differentiation was also altered in K15ΔNLef1 mice. Typically, two 
SG are attached to one HF in wt tail epidermis. In contrast, 3.5 months old 
K15ΔNLef1 not only exhibited enlarged SG, but also displayed multiple sebaceous 
lobules attached to one HF (n=2 mice/line). Surprisingly, with an increase in age an 
augmentation in the number of sebaceous lobules per pilosebaceous unit was seen 
(A_line n=3; B_line n=5; C_line n=2). Up to seven SG lobules were detected in 
epidermal whole mounts of B_and C_K15ΔNLef1 mice. This phenotype correlated 
with the transgene copynumber integrated since only a mild increase in number of 
SG lobules could be seen within the low expressing A_K15ΔNLef1-line.  
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Accessorily to the increase in SG differentiation in 7-19 months old B_and 
C_K15ΔNLef1 tail skin, the bulge region of the HF appeared more compact and 
thickened. HF were occasionally degenerated and deformed (Fig 34). In some cases, 
invaginations along the HF were observed, presumably resemble cyst like structures 
or ectopic SG (Nöbel, 2009). Notably, the typical pattern of HF triplets was frequently 
lost in epidermal whole-mounts derived from B_and C_K15ΔNLef1 tail epidermis. 
Taken together, these results indicate that mutant Lef1 in the HF bulge directs the 
migration of HFSC and lineage commitment towards the IFE and SG.  
 
 
 
Fig 34: Characterisation of K15ΔNLef1-mice (F0-F2 generation) 
Epidermal tail whole-mounts isolated from K15ΔNLef1 mice show an altered differentiation. 
SG are enlarged and amplified. B_C_K15ΔNLef1 mice display shortened HF. Occasionally 
invaginations at the deformed HF (nSG/cyst) are found. The HF bulge seems to be more 
compact.  
 
Expression of the transgene was analysed conducting immunofluorescent studies on 
paraffin sections and epidermal whole-mounts. In 2.5 months aged K15ΔNLef1 skin 
(B and C line, n=2 mice/line), myc-tagged ΔNLef1 was detected in the HF bulge 
compartment, but also in parts of the IFE, at the periphery of the multiplied SG and 
occasionally in the HF, indicating a stability of the transgene. Immunological 
detection of nuclear myc-tag in A_K15ΔNLef1 skin failed, probably due to low 
expression levels of the transgene. In wt skin, no immunofluorescent signal was 
observed with anti-myc-tag antibodies.  
Most strikingly, B_C_K15ΔNLef1 founder mice developed spontaneous skin tumours 
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with the age of 16 months (C_line) and 19 months (B_line). Histological analyses and 
immunostainings (Nöbel, 2009) revealed strong expression of the sebocyte marker 
SCD1 within the tumours. K14 was detected in the basal layer of keratinocytes of 
tumour lobules and within thickened and invaginated areas of the IFE. Furthermore, 
transgene expression was detected in the tumours as demonstrated by 
immunofluorescent analysis 
 These studies demonstrate that sebaceous adenomas had emerged in 
K15ΔNLef1 animals, the same tumour types that K14ΔNLef1 mice develop 
spontanously.  
To investigate whether ΔNLef1 acts as tumour promotor in the HF bulge, we 
subjected B_C_K15ΔNLef1-animals (F1 and F2 generation) to a one-step 
carcinogenesis protocol. A single treatment of B_C_K15ΔNLef1-animals with 
subcritical dose of DMBA resulted in the formation of sebaceous adenomas, whereas 
DMBA-treated control littermates never developed tumours.  
Notably, tumour growth and frequency in DMBA-treated K15ΔNLef1 mice was similar 
to age matched DMBA-treated K14ΔNLef1 animals, albeit the number of tumours per 
mouse was decreased and the incidence slightly delayed in K15ΔNLef1 by 1-
2 weeks (B_K15ΔNLef1, n=5) and 4 weeks (C_K15ΔNLef1, n=3).  
Further immunological analyses (Nöbel, 2009) revealed that induced tumours in 
B_C_K15ΔNLef1-animals (n=17 tumours of 4 B_K15ΔNLef1-animals, n=7 tumours of 
3 C_K15ΔNLef1-animals) and tumours derived from K14ΔNLef1-animals express 
similar epidermal markers, such as SCD1, K14 and K10. Additionally, tumours of 
B_C_K15ΔNLef1 and K14ΔNLef1-animals displayed the same number of 
proliferating (Ki67+ve) keratinocytes at the periphery of the tumour lobules.  
 Thus, dominant-negative Lef1 expressed in the HFSC compartment promoted 
sebaceous tumourigenesis.  
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4 Discussion 
Multiple stem and progenitor cell populations are responsible for spontaneous 
regeneration of mammalian epidermis consisting of an IFE with associated HF and 
SG (Cotsarelis, 2006; Fuchs and Horsley, 2008; Jaks et al., 2008; Jaks et al., 2010). 
It has been well documented that long-lived stem cells from the HF niche (bulge) are 
capable to sustain hair growth (Blanpain et al., 2004; Jaks et al., 2008; Liu et al., 
2003; Morris et al., 2004). Although there are implications that uni- or bipotent 
progenitors (Horsley et al., 2006; Jensen et al., 2009; Jensen et al., 2008; Nijhof et 
al., 2006; Snippert et al., 2010) are involved to regenerate the upper integral parts of 
the epidermis, the cellular mechanism of SG renewal during tissue homeostasis still 
has to be uncovered. Over the last years, several SC/progenitor compartments have 
been identified within the pilosebaceous unit, but it is not clear if these stem and 
progenitor cells act autonomously or are related to each other.  
To investigate a potenital function of SC from the bulge HF niche, we have developed 
an tamoxifen-inducible Cre-mouse model. We aimed to specifically target HFSC by 
using the K15 regulatory sequence (Liu et al., 2003) to drive the inducible Cre-
recombinase fused to the mutated estrogen receptor (Indra et al., 1999), thereby 
generating the K15CreER(G)T2-mice. By crossing K15CreER(G)T2 strain to Cre-
sensitive reporter mice R26RLacZ (Soriano, 1999) and R26REYFP (Srinivas et al., 
2001), bulge SCs as well as all descending cell lineages could be visualised.  
In this PhD project a mouse model was generated providing a powerful tool to 
monitor the fate of HFSC on a single cell level under homeostatic and 
pathophysiological conditions (e.g. epidermal tumourigenesis). 
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4.1 Development of a transgenic mouse model to trace the 
 fate of HFSC-derived progeny on a single cell level 
Eight K15CreER(G)T2 lines were generated and two founder lines A_ 
K15CreER(G)T2 and C_K15CreER(G)T2 were specific for Cre activation in the HF 
bulge and differed only in the number of targeted cells:  
i. C_K15CreER(G)T2 founder line exhibited high levels of activated Cre-
recombinase in the bulge region and Cre-reporter gene activation was monitored in 
many keratinocytes within the HFSC compartment. This high expressing 
C_K15CreER(G)T2 strain represents an excellent tool to genetically target the HFSC 
compartment and will be suitable for the specific manipulation of the HFSC niche. 
Indeed, the number of labelled bulge cells using C_K15CreER(G)T2 was very similar 
to previously published conditional K15Cre mouse models (K15CrePR or 
K15CrePR*), which can be induced by the application of the progesterone analgon 
RU486 (Morris et al., 2004).  
 ii. In contrast to the former generated inducible K15Cre strains (Malanchi et 
al., 2008; Morris et al., 2004; Youssef et al., 2010), individual cells could be targeted 
to the HFSC compartment using A_K15CreER(G)T2-mice. Therefore, the 
A_K15CreER(G)T2 line provides an excellent and novel tool to follow the fate of 
HFSC-derived progeny on a single cell resolution. In combination with the whole-
mount technique (Braun et al., 2003), a three dimensional, complete and detailed 
lineage analysis of every genetically marked cell of the entire tail epidermis is now 
feasible. 
 The characterisation of targeted cells by A_K15CreER/G)T2 mice at initial time 
points (day 1-2) confirmed that they were confined specifically to the bulge region 
since individually labelled keratinocytes co-localised with established HFSC markers 
such as K15 or an intense Itga6 signal and LRC.  
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4.2 Multipotency of individually labelled bulge cells 
Previously, lineage analyses of HF regeneration have been performed applying the 
inducible K15CrePR and K15CrePR* lines. These pioneer studies were among the 
first lineage tracing experiments conducted in the skin demonstrating that K15-
targeted cells were multipotent to regenerate the entire HF including all different hair 
lineages (Morris et al., 2004). 
Consistent with these reports, single HFSC-derived progeny labelled by 
A_K15CreER(G)T2 mice participated in HF regeneration: Lineage tracing during the 
HFSC mobilisation phase demonstrated that HF were repopulated by HFSC-derived 
progeny, even after tracing through another hair cycle (28 days) or for 6 months in 
long-term studies. Taken together, these data demonstrated that the genetically 
targeted bulge cells utilising K15CreER(G)T2 mice indeed were long-lived and 
multipotent HFSC.  
4.3 HFSC contribute to epidermal homeostasis 
Until now, it was controversially discussed whether SC from the HF bulge actually 
contribute to spontaneous regeneration of other integral parts of the epidermis during 
skin homeostasis (Morris et al., 2004; Horsley et al., 2006; Blanpain et al., 2004; Levy 
et al., 2005; Blanpain and Fuchs, 2009; Jaks et al., 2010). It has been reported that 
SC from the bulge are able to reconstitute the IFE upon wounding or tissue damage 
(Ito et al., 2005; Ito et al., 2007; Langton et al., 2008; Levy et al., 2005; Levy et al., 
2007).  
The fate mapping analysis of single HFSC targeted by A_K15CreER(G)T2-mice 
presented in this thesis now provides strong evidence that besides HF renewal, 
individual HFSC-derived progeny is also capable to regenerate the SG and IFE 
during skin homeostasis.  
4.3.1 Regeneration of the SG 
Lineage tracing experiments performed with A_K15CreER(G)T2 mice during the 
resting phase of the hair cycle revealed that single HFSC-derived progeny drove SG 
renewal. First, YFP+ve keratinocytes were detected at the inner periphery of the SG 
which is located between SD and the lower tip of the SG. Subsequently, the entire 
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SG was repopulated by HFSC-derived progeny within a time frame of 5-7 days, thus 
implying a rather dynamic and fast turn-over of SG. In contrast, the HF compartment 
is replaced in a cyclic fashion with growth phases (anagen) lasting about 2 weeks 
(Alonso and Fuchs, 2006). Interestingly, the repopulation of one of the two glands by 
individual HFSC-derivates was observed in a high frequency, indicating that the 
renewal of both glands needs the activation of more than one HFSC.  
Detailed statistical analyses of traced cells within a time frame of 7 days revealed that 
labelled keratinocytes were displaced from an exclusive localisation in the bulge to 
the SD and SG and a more complex pattern.  
 Thus, these data demonstrate that HFSC-derived progeny left the HF bulge 
region to contribute to the highly dynamic process of SG regeneration. In addition, 
many labelled bulge cells remained in the HF niche and will most likely be activated 
at a later time point for tissue regeneration and replenishment of the bulge SC pool. 
The spatial changes of HFSC-derived progeny towards the SG have been confirmed 
by FACS analyses. In the course of tracing (6 days of chase), a deprivation of 
YFP+ve/CD34 positive bulge cells (by 28 %) and an elevation of YFP/Lrig1+ve 
population (by 89 %) was detected (H. Brylka, personal communication and 
Petersson et al., submitted). These results were consistent with our observation that 
besides the persistence of LRC in the bulge, the BrdU label was also diluted upwards 
the UI and SG.  
 The possibility that the K15 promotor fragment itself was expressed in the SG 
or the CreER(G)T2 system was more sensitive to the hormone analogon tamoxifen in 
the SG could be ruled out, since Cre reporter gene activation in the higher expressing 
C_K15CreER(G)T2-line was restricted to the bulge only at early tracing times. 
Furthermore, no increased number of labelled SG cells was observed over time of 
tracing demonstrating that SG homeostasis is not maintained by resident YFP+ve 
progenitors.  
 For future studies, it would be beneficial to perform live cell imaging to directly 
follow the migration, propagation and lineage commitment of individual HFSC-derived 
progeny. Therefore, cultivation of epidermal whole-mounts would not only allow time 
laps analyses of labelled HFSC-derived progeny, but also would open up the 
opportunities for manipulating growth and differentiation of whole-mounts in vitro. 
Addition of a distinct ligand or inhibitor of a certain pathway could be useful to study 
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the direct effects on individual cells and the consequences for homeostasis of the 
pilosebaceous unit. 
 Tracking HFSC-derived progeny at distinct phases of the hair cycle provided 
new insights into temporal control of SG renewal. Activation of HFSC for SG 
homeostasis occurred continuously and independently of the cyclic mobilisation of 
HFSC required for HF renewal. Thus, different signalling cues must exist to instruct 
HFSC either to move upwards to renew the SG or to migrate downwards to sustain 
hair growth. However, these signals are still elusive and need to be identified in the 
near future. 
 
4.3.2 Regeneration of the IFE 
HFSC-derived progeny additionally participated in the regeneration of the IFE. 
Intriguingly, YFP+ve keratinocytes were detected in clusters emanating from the JZ 
towards the IFE. Since no increase in YFP signal was seen at 28 days of tracing, it 
seems quite likely that labelled cells did not permanently reside in this compartment. 
Interestingly, a contribution of HFSC-derived progeny to IFE renewal was enhanced 
during HFSC mobilisation phase (telogen to anagen transition) compared to the initial 
telogen tracing experiment. Ongoing statistical analyses will help to quantify and 
validate these observations.  
 For the future, it will be challenging to investigate whether the regeneration of 
the SG and the IFE are interconnected and originate from the same HFSC. An 
elegant way to allow the visualisation of cell lineages derived from one particular SC 
in vivo was recently demonstrated for the nervous system. Livet et al. have generated 
a neuronal specific Cre reporter mouse model (Thy1-brainbow), which in response to 
active Cre recombinase expresses multiple fluorescent proteins in a mosaic fashion. 
This is achieved by the use of incompatible loxP sites to generate exclusive 
recombination events and by inserting loxP sites in opposite orientation positioned in 
series to induce several recombination events. This resulted in the expression of 
multiple fluorescent proteins from a single transgene upon Cre mediated 
recombination. Therefore, a reconstruction of hundreds of neighbouring axons and 
multiple synaptic contacts exhibiting approximately 90 colours was impressively 
demonstrated (Livet et al., 2007). With respect to our lineage tracing experiments 
these brainbow cassette could be adapted to a ubiquitous or skin specific promoter. 
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This would provide a powerful tool not only to perform clonal analyses derived from 
one particular labelled HFSC but also to isolate and analyse the molecular profile of 
clones derived from a single HFSC. With regard to the regeneration of the SG and 
the IFE, one could directly investigate whether progeny emanated from one HFSC 
gives rise to the IFE and the SG or whether renewal of the IFE and SG are achieved 
independently.  
4.4 A hierarchy of stem and progenitor cells drives 
 epidermal renewal 
During the process of SG regeneration, single HFSC-derived progeny transits 
different SC/progenitor compartments of the pilosebaceous unit as verified by co-
immunofluorescent analyses for marker molecules. They migrated through the 
MTS24antigen/Plet1+ve UI (Nijhof et al., 2006; Raymond et al., 2010), the JZ 
(Lrig1+ve) (Jensen et al., 2009) and the SD. At the inner periphery of the SG, Lrig1 
seemed to mark the trail of genetically labelled keratinocytes towards the lower tip of 
the SG. FACS-analyses (performed by H.Brylka, Niemann lab, Petersson et al., 
submitted) verified and manifested that HFSC-derived progeny indeed gave rise to 
the SC/progenitor populations of the UI (MTS24) and JZ (Lrig1). Additional molecular 
analyses of SG-associated marker molecules revealed that both, YFP/Lrig1+ve and 
Itga6/Lrig1+ve cells, exhibited elevated expression levels of Blimp1, a marker for 
unipotent SG progenitors (Horsley et al., 2006) and the sebocyte marker SCD1 
(Sampath et al., 2009). Thus, both populations had adopted sebaceous fate. Notably, 
the expressional change was quite similar comparing the subpopulation of YFP+ve 
keratinocytes in the Lrig1+ve compartment and the basal cell pool of the Lrig1+ve 
population. Of note, expression levels for bulge markers of YFP/Itga6 and 
CD34/Itga6 at 2 days chasing time were quite similar confirming that the initial 
genetically marked cells were indeed bulge stem cells.  
Taken together, these data strongly imply that the different classes of 
SC/progenitor niches do not operate autonomously but are rather linked into a 
hierarchic system (Fig 35). Ongoing transplantation experiments and clonal analyses 
in vitro of YFP+ve keratinocytes isolated from different SC/progenitor compartments 
will prove this hierarchy on a more functional level. 
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Fig 35: Hierarchy of epidermal SC 
K15+ve SC population gives rise to HF, SG and the HF niche itself. Lgr6+ve (dark green) from 
the central isthmus and Lrig1+ve cells (blue) at the JZ contain bipotent progenitors that renew 
the SG or the IFE. Thus, multipotency decreases as cells move upwards, whereas the 
differentiation potential increases. A Lgr5-targeted SC population at the lower base of the HF 
is capable to only regenerate the HF. 
 
 
Another emerging issue is how the different niches and the hierarchy are established 
during early morphogenesis. Several data suggest that during early stages of HF 
morphogenesis (E18.5), a common founder population (being positive for Lgr5, Lgr6, 
Lrig1 and Sox9) exists which is confined to the ORS of the developing HF (Jaks et 
al., 2008; Jaks et al., 2010; Nowak et al., 2008; Snippert et al., 2010). To dissect a 
hierarchy potentially established during HF morphogenesis, it will be very interesting 
to investigate the relationship between K15-targeted cells and the other described 
markers during early HF morphogenesis.  
 But what is the functional significance of the different progenitor pools within 
the pilosebaceous units during adult life? Previously, functional assays of different 
isolated SC/progenitor populations of the pilosebaceous unit were performed by 
several laboratories to prove the stem cell identity and their regenerative potential. 
Isolated bulge stem cells as well as MTS24 and Lrig1+ve keratinocytes form an 
increased number of highly proliferative stem cell colonies (holoclones) in vitro (Nijhof 
et al., 2006; Jensen et al, 2008; Jensen et al, 2009). In addition, all three isolated cell 
populations gave rise to a multilayered IFE, HF and SG in transplantation 
experiments, thus containing multipotent SC. For the future, more sensitive assays 
have to be evolved to distinguish SC potential of different epidermal progenitor 
populations and to test a hierarchic relationship on a functional level. Therefore, it 
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would be quite challenging to specifically target and ablate Lrig1 or MTS24 positive 
progenitor populations in HFSC-derived progeny to investigate the functional 
implications of these diverse SC/progenitor compartments within the pilosebaceous 
unit.  
4.5 Signalling cues governing epidermal homeostasis 
It is intriguing to speculate that during epidermal homeostasis, signals sent from the 
surrounding microenvironment instruct SC and its derivates to migrate into diverse 
directions to renew all integral parts of the epidermis. Based on our own results and 
recent reports by other laboratories (Greco et al., 2009; Horsley et al., 2006; Jaks et 
al., 2008; Jensen et al., 2009; Jensen et al., 2008; Nijhof et al., 2006; Snippert et al., 
2010; Tumbar et al., 2004; Zhang et al., 2009; Zhang et al., 2010) a model 
comprising 2 “fate determination centers“ governing the renewal of the HF, SG, IFE 
and the HFSC niche itself could be proposed (Fig 36): The first signal center is 
located at the HF bulge, where the mobilisation of HFSC either to migrate towards 
the HF or upwards to the SG/IFE is controlled. Recently, a Lgr5+ve SC population 
targeted by Wnt signals and located at the lower part of the HF near to the secondary 
HG has been identified and Lgr5+ve progeny is involved HF renewal (Jaks et al., 
2008). More recently, it has been shown that Lgr6+ve SC located above the HF bulge 
and below the MTS24+ve cell compartment give rise to the IFE and SG (Snippert et 
al., 2010). In contrast to Lgr5, Lgr6 is not a Wnt target, suggesting that an active Wnt 
signal below the bulge sustains hair growth and a repressed Wnt signalling above the 
bulge leads to renewal of the SG and IFE. Notably, K15ΔNLef1 mice, where β-
catenin/Lef1 mediated signalling is repressed in the HFSC niche, display multiplied 
SG and hyperproliferative IFE, indicating that impaired Wnt/Lef1-signalling in the HF 
bulge directs the migration of HFSC upwards the HF. Thus, one could speculate that 
signals controlling lineage differentiation also govern migration. 
 Once they exit the HF bulge towards the upper integral parts of the epidermis, 
HFSC-derived progeny reaches the 2nd cell fate determination center, the JZ, where 
YFP/Lrig1+ve SC derivates could be directed to either regenerate the SG or the IFE. 
It has been shown that Lrig1 is a c-myc target and Lrig1 expression resulted in a 
reduced c-myc activity. Therefore, at the 2nd cell fate determination center, c-myc 
mediated signals could govern proliferation and cell type specification into lineages of 
the IFE and/or SG. Previously, it has been shown that HFSC lacking Notch signalling 
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contribute to the homeostasis of the IFE, proposing that Notch signalling is required 
to prevent migration of HF bulge progeny to the IFE. So far, a role for Notch 
signalling in migration and SG renewal has not been reported (Demehri and Kopan, 
2009).  
 
 
 
Fig 36: Potential role of cell fate determination centers for epidermal regeneration 
4 independent signalling events are needed to renew the HF, SG, IFE and the HFSC niche 
itself. Fate determination is controlled in 2 centers. At the 1st center bulge cells are instructed 
either to move up- or downwards the HF or to replenish the HFSC niche. Fate decision for 
SG or IFE renewal is determined at the UI/JZ (2nd center). 
 
4.6 Implications for ageing 
Three important characteristics of aged skin are: shortened HF with reduced 
regenerative capacity enlarged SG and a thin IFE (Zouboulis et al., 2008a). 
Interestingly, despite an enhanced expression of cellular senescence markers such 
as INK4a (Jacobs et al., 1999), it has been shown that epidermal SC are maintained 
throughout adult life (Stern and Bickenbach, 2007). However, activity of 
surrounding/extrinsic signalling networks is altered in aged skin. For instance, it has 
been demonstrated that aged skin exhibits reduced expression levels of Igfbp3 
(insulin-like growth factor binding protein3) (Giangreco et al., 2008). Furthermore, 
impaired Ifg/Ifgbp signalling has implications on the differentiation of the epidermis 
and HF shortening being indicative for premature ageing (Edmondson et al., 2003; 
Liu et al., 1993; Weger and Schlake, 2005).  
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Thus, these age-associated changes in signalling could lead to an imbalanced 
activation of bulge SC at the different cell fate determination centers (Fig 37). This 
could result in an enhanced mobilisation for SG renewal and reduced activation for 
HF or IFE regeneration. To investigate if HFSC mobilisation and activation is altered 
in aged skin, lineage tracing experiments could be conducted in old mice. 
Furthermore, it will be interesting to ablate or over-express age-associated factors 
such as INK4a or Igf/Igfbp signalling in the HFSC niche and to study the 
consequences on epidermal regeneration. 
 
Fig 37: Imbalanced activation of HFSC could be accompanied with ageing 
(A) HF and associated SG in young tail epidermis are organised in triplicates. The activation 
of HFSC for HF, SG, self-renewal and IFE are in a tight balance.  
(B) HF of aged tail epidermis are shortened, possibly due to a reduced activation of HFSC for 
HF renewal. In contrast, enlarged SG could be a result of an enhanced mobilisation of HFSC 
for SG renewal. Additionally, the strict organisation of three HF in close proximity is lost in 
aged tail epidermis.  
 
4.7 The HFSC niche exhibits a heterogeneous population 
Our long term tracing experiments have shown that targeted HFSC were competent 
to replenish the HFSC niche itself. Notably, the HF bulge contained an elevated pool 
of labelled keratinocytes (3 fold) compared to the number of initially labelled HFSC. 
This could be a result of symmetric cell division at some stage of the long tracing 
period. Accordingly, a recently proposed model for HF renewal predicts that the self-
renewing divisions within the HF bulge are symmetric in respect to their positioning 
towards the basement membrane. In contrast, divisions of short-lived progenitors in 
close proximity to the secondary HG seem to be orientated more asymmetrically 
(Zhang et al., 2010). This model would imply that the expansion of the SC pool and 
the mobilisation for the regeneration of the SG and IFE are assessed separately by 
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means of symmetric and asymmetric positioning towards the basement membrane. 
Furthermore, it is intriguing to speculate that the size of the SC pool might be 
controlled by an inhibitory feedback loop due to cell-cell contacts.  
 Our analyses clearly indicate that the HFSC niche exhibits a heterogeneous 
cell population consisting of a pool of SC dividing infrequently (silent SC) and more 
frequently (active SC). During SG renewal, some YFP+ve LRC were diluted towards 
the UI, whereas other LRC remain in the HFSC compartment. This is consistent with 
previous reports demonstrating that some bulge cells retained the label for longer 
periods indicating that they subsisted in a more quiescent state. In contrast, another 
population of LRC rapidly lost their label upon participation in epidermal regeneration  
(Blanpain et al., 2004; Tumbar et al., 2004; Waghmare et al., 2008). 
 Taken together, the data support the “ two SC population“ hypothesis recently 
postulated (Li and Clevers, 2010). This model suggests that two SC populations 
reside within the same niche: (i.) A more primed and activated SC population that 
contributes to normal tissue homeostasis and (ii.) a highly competent quiescent SC 
population. The quiescent SC population can be activated in response to injury, safe-
guarding upon loss of the primed SCs. According to this model, maintenance and 
activation of the SC niche are balanced by secreted signalling proteins at segregated 
(“stimulatory“ and “inhibitory“) zones. It has been demonstrated that Wnt and BMP 
signals are key players in these processes (Fuchs and Segre, 2000; Horsley et al., 
2008; Kobielak et al., 2007; Rendl et al., 2008). To keep SC in a quiescent state, Wnt 
signalling is inhibited, whereas BMP-pathway is stimulated. The mirror image reflects 
the activated SC population. Besides the skin, there is compelling evidence for a 
heterogeneous composition of the SC niche from the hematopoetic system (Cheshier 
et al., 1999; Kiel et al., 2007; Wilson et al., 2008) and the intestine (Barker et al., 
2007; Potten et al., 1997; Sato et al., 2009).   
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4.8 Impaired Lef1 signalling in the epidermis controls 
 sebaceous commitment of HFSC-derived progeny 
Impairment of Lef1-signalling in the epidermis (K14ΔNLef1 mice) promotes the 
development of ectopic SG along the deformed HF at expansion of HF differentiation 
(Niemann et al., 2002).  
4.8.1 Composition of the HFSC niche 
Molecular and immunofluorescent analyses of K14ΔNLef1 skin revealed that the 
expression levels of established HF bulge markers (K15, CD34) were decreased. In 
contrast, fate mapping experiments of HFSC-derived progeny in K14ΔNLef1 mice 
clearly demonstrated that the targeted K15 promotor fragment was active in the 
deformed bulge at initial time points. Compared to the clonal analyses under 
homeostatic conditions, the number of labelled cells confined to the bulge region was 
elevated. This increase indicates that mutant Lef1 promotes the activation and 
proliferation of labelled HFSC.  
Concomitant to the smaller size of the bulge compartment, a dramatic decrease in 
NFATc1 expression in K14ΔNLef1 skin could be detected. NFATc1, a key regulator 
of SC quiescence, is activated by BMP signalling (Horsley et al., 2008) and our data 
indicate that the more silent SC population is deprivated. It would be interesting to 
analyse if BMP signalling is altered in K14ΔNLef1 mice. Long term tracing 
experiments within the K14ΔNLef1 mouse model showed that small aggregates of 
labelled cells still remained in the bulge, thereby demonstrating that the SC pool in 
the HF bulge is not completely exhausted.  
 Taken together, our data suggest that the HFSC niche of K14ΔNLef1 mice 
exhibits an enhanced pool of activated SC and that the reservoir of more dormant SC 
is diminished. 
 
4.8.2 Ectopic SG originate from HFSC 
From our lineage tracing experiments within the K14ΔNLef1 mouse model we have 
learned that HFSC-derived progeny not only contributes to the regeneration of the 
enlarged upper SG, but also drives formation of ectopic SG (Fig 38). Indeed, a 
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majority of labelled SC-derivates migrated towards the ectopic SG and were 
committed to sebaceous lineage as they co-expressed SCD1, a sebocyte 
differentiation marker.  
 Thus, HFSC from the bulge region could be identified as cellular source for 
ectopic SG development. In addition, mutant Lef1 not only determines the fate 
decision of HFSC but also affects the migration of HFSC-derived progeny. HFSC-
derived progeny is instructed either to move upwards to repopulate the enlarged SG 
and downwards to drive formation of ectopic SG. The underlying mechanism how 
migration is controlled by Lef1 still remains elusive.  
4.8.3 Establishment of new progenitor niches 
The increase in SG fate in K14ΔNLef1 mice was accompanied by an elevated 
number of progenitors directing SG differentiation. The molecules being associated 
with sebaceous lineage (Lrig1 and MTS24/Plet1) were also localised to the perimeter 
or branching ducts of the ectopic SG. These data imply that the induction of de novo 
SG by overexpressing dominant negative Lef1 required the establishment of new 
SG-associated progenitor niches. This finding was validated by qRT-PCR analysing 
marker molecules associated with SG fate specification. TenascinC, a known target 
of the UI (MTS24antigen+ve) compartment (Nijhof et al., 2006), is up-regulated in 
K14ΔNLef1 mice. Additionally, Keratin6a, recently been discovered to be strongly 
expressed in the sebaceous duct (Gu and Coulombe, 2008), was upregulated in 
K14ΔNLef1 epidermis. Future experiments will evaluate whether the expression 
levels of other described SG-associated progenitor marker such as Lrig1, Blimp1 and 
Lgr6 are also differentially regulated on a transcriptional level. 
 The presented fate mapping studies clearly show that HFSC-derived progeny 
transits the new etablished progenitor niches during development of ectopic SG in 
K14ΔNLef1 mice. This again supports our view of a hierarchy of HFSC and 
MTS24/Plet1 and Lrig1+ve progenitors. One could speculate that SG morphogenesis 
is recapitulated during the process of ectopic SG formation, but this awaits further 
investigations.  
 Previous reports have delineated a crucial role for c-myc signalling in 
controlling proliferation and cell type specification of the IFE and SG (Watt et al., 
2008). Interestingly, c-myc and its target Nucleolin were down-regulated in 
K14ΔNLef1 epidermis. Therefore, Lef1 and c-myc might have an independent role in 
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controlling sebaceous fate specification. It seems possible that an elevated pool of 
Lrig1 could mediate c-myc signalling to regulate sebaceous fate decision. 
4.9 Role of HFSC in epidermal tumourigenesis 
Several studies provide evidence that de-regulated β-catenin signalling causes a 
variety of cancers, including skin tumours (Owens and Watt, 2003; Polakis, 2000). 
Activating mutations have been detected in human pilomatricomas (Chan et al., 
1999) and mouse models stimulating β-catenin signalling form hair tumours 
(trichofolliculomas and pilomatricomas) (Gat et al., 1998). Conversly, mutations in the 
β-catenin binding domain of Lef1 have been found in a high frequency in human 
sebaceous tumours, indicating that also a repression of β-catenin-mediated Lef1 
signalling results in cancer development (Takeda et al., 2006). Accordingly, our 
transgenic mouse model with an epidermal expression of mutant Lef1 (ΔNLef1) 
lacking the β-catenin binding domain (K14ΔNLef1) exhibits spontaneous 
tumourigenesis. These tumours are sebaceous adenomas and papillomas with 
sebocyte differentiation (Niemann et al., 2002). Since ΔNLef1 itself acts as a tumour 
promotor, these tumours can also be induced by a single application of a carcinogen 
(DMBA) to initiate tumour growth (Niemann et al., 2007). 
Therefore, the development of sebaceous adenomas following 4 weeks after tumour 
initiation provides an excellent tool to study distinct stages of tumour formation and 
origin and cause of tumourigenesis.  
According to the rationale of cancer stem cells (CSC) (Bonnet and Dick, 1997; Lobo 
et al., 2007; Visvader and Lindeman, 2008; Wang, 2010; Wang and Dick, 2005) 
sebaceous tumour formation in K14ΔNLef1 mice is initiated and driven by a 
subpopulation of self-renewing CSC.  
To analyse whether HFSC and its derivates were transformed into a CSC, label 
retention and fate mapping experiments were assayed within the K14ΔNLef1 tumour 
model. Label retention studies revealed that LRC localised to the deformed HFSC 
niche showed an increased recruitment into the cell cycle upon tumour initiation, 
indicating that HF progenitors were activated in the process of tumour development 
(C. Niemann, unpublished data and data not shown).  
The protocol to isolate epidermal whole-mounts derived from was adapted and 
enabled a three dimensional and detailed lineage analyses of HFSC-derived progeny 
at early and late stages of sebaceous tumourigenesis. At early stages, an elevated 
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number of labelled cells could be detected in the deformed HF bulge, indicating that 
DMBA treatment causes an enhanced mobilisation of HFSC. Concomitantly with 
tumour progression, HFSC-derived progeny was detected in early lesions and the 
entire sebaceous tumours including the more differentiated areas.  
From these fate mapping studies we conclude that HFSC-derived progeny indeed 
contributes to sebaceous adenoma formation (Fig 38). In the future, we aim to isolate 
HFSC-derived progeny at different stages of tumour development. Subsequent serial 
transplantations and clonal analyses of the isolated cells will prove their tumourigenic 
potential. Important issues will be how many cells are required to recapitulate 
tumourigenesis and to calculate the number of self-renewing CSC within the isolated 
cell population.  
Additionally, it will be interesting to investigate which tumour type is induced to gain 
information about multipotency and plasticity of the isolated cell fractions. 
Fig 38: HFSC-derived progeny contributes to ectopic SG and sebaceous adenoma 
formation.  
Mutant Lef1 mobilises HFSC from the deformed bulge region to drive ectopic SG renewal. 
HFSC-derived progeny transits different newly established progenitor compartments thereby 
creating a hierarchy of different classes of stem and progenitor cells. Upon tumour initiation, 
clonal expansion of labelled cells was found in early lesions and sebaceous tumours.   
 
Here, we present data supporting the idea of CSC driving formation of skin tumours. 
It was found previously, that a large number of tumourigenic CD34-expressing cells 
reside in murine squamous cell carcinomas (SCC). Interestingly, the published data 
indicate that β-catenin was essential for maintaining the tumour-initiating potenial of 
the CD34+ve tumour cells (Malanchi et al., 2008).  
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More recently, lineage tracing experiments utilising a Cre-sensitive tumour-mouse 
model for basal cell carcinoma (BCC) revealed that progenitor cells from the basal 
layer and not from the HFSC niche represent the cell of origin generating the bulk of 
the tumour (Youssef et al., 2010). 
To this end, it is unclear whether labelled HFSC itself or HFSC-derived progeny is 
targeted by mutations resulting in tumour development.  
Due to the high plasticity within the epidermal tissue, it is intriguing to speculate that 
all progenitors could adopt SC characteristics and therefore become CSC. 
Alternatively, a certain hierarchy of HFSC and SG progenitors could be established 
during sebaceous tumourigenesis. Therefore, we will analyse if labelled HFSC give 
rise to an elevated progenitor pool of Lrig1, MTS24 or Lgr6+ve cell populations within 
the tumour model. To investigate if the labelled HFSC itself serves as unique cellular 
source during sebaceous tumourigenesis, deletion experiments of K15-targeted cells 
at different stages of tumour development are planned.  
4.10 Manipulating Lef1 signalling in the HFSC niche 
4.10.1 Impaired epidermal differentiation 
To investigate whether mutated Lef1 signalling in the HFSC niche affects epidermal 
regeneration and is sufficient to drive tumourigenesis, K15ΔNLef1 transgenic mice 
were generated. K15ΔNLef1 mice showed a normal development, but displayed a 
progressive reversible hair loss. Histological analyses revealed that the IFE was 
hyperproliferative. In addition, sebocyte differentiation was stimulated. All K15ΔNLef1 
mice displayed multiple sebaceous lobules attached to one HF, whereas the wt 
controls exhibited only two SG within one pilosebaceous unit (Nöbel, 2009). Notably, 
an augmentation of sebaceous lobules was seen from 7 months of age onwards. In 
contrast, HF were degenerated and deformed occasionally. Often, HF were 
shortened indicating that mobilisation of HFSC for HF renewal is reduced. 
Interestingly, the typical organisation of HF triplets was frequently lost in epidermal 
whole-mounts.  
Taken together, these data imply that dominant negative Lef1 in the HFSC causes an 
imbalanced mobilisation of HFSC leading to an image which is typically seen in aged 
skin. Therefore, qRT-PCR analysing ageing-associated genes such as pINK4a will 
prove if the phenotype of K15ΔNLef1 is coupled to premature ageing.  
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4.10.2 Sebaceous tumourigenesis in K15ΔNLef1 mice 
Most strikingly, K15ΔNLef1 mice developed spontaneous sebaceous tumours. 
Sebaceous tumours can also be induced by the application of a single subthreshold 
dose of DMBA (Nöbel, 2009).  
These data proof that targeted expression of ΔNLef1 within HFSC niche also acts as 
a tumour promotor and targeting ΔLef1 to the HFSC is sufficient to drive sebaceous 
tumour formation. Thus, it seems possible that cells from the HF bulge are 
transformed into a CSC.  
4.11 Perspectives 
The data presented in this thesis provide novel insights into the cellular mechanisms 
of epidermal regeneration. HFSC are activated by at least 4 different signals to renew 
the SG, HF, IFE and to replenish the SC niche. Future experiments will focus on the 
molecular signals determining which epidermal compartment is regenerated thereby 
directing migration of HFSC-derived progeny. An imbalanced mobilisation of HFSC 
could promote an enhanced regeneration of one of these compartments, thereby 
allowing a certain plasticity within the tissue and responsiveness to damaging agents. 
This is not only important for tissue repair after injury, but also has major implications 
for ageing. Future fate mapping and manipulation experiments will address the 
question whether ageing is accompanied by an enhanced mobilisation of HFSC for 
SG renewal and reduced activation for HF regeneration. Our data demonstrated that 
HFSC-derived progeny gives rise to different epidermal progenitor compartments 
during SG homeostasis and ectopic SG formation. It will be challenging to identify 
which signals control the integration of the different SC/progenitor into a hierarchic 
system. Fate mapping studies within an inducible tumour model identified HFSC-
derived progeny as cells of origin generating sebaceous tumours. Further analyses 
will be needed to characterise their tumourigenic potential in more detail. Ablation of 
HFSC-derived progeny will prove whether these cells serve as unique source driving 
sebaceous tumourigenesis. Analysing the molecular signature and crucial mutations 
of tumour-initiating cells might have a relevant diagnostic and therapeutic value. 
Mutant Lef1 in the HFSC niche drives sebaceous tumourigenesis, which raises the 
question whether tumour development is dependent on SC intrinsic mutations or is 
rather caused by an impaired crosstalk with signals provided by the 
microenvironment. 
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5 Summary 
Mammalian epidermis is a highly dynamic epithelium comprising the interfollicular 
epidermis, hair follicles (HF) and associated sebaceous glands (SG). Spontaneous 
regeneration and cellular turn over of each of these compartments is maintained by 
multiple stem cell (SC) and progenitor populations (Cotsarelis, 2006; Fuchs and 
Horsley, 2008). Although there are implications that different SC/progenitors 
participate in SG regeneration, the cellular process of SG maintainance still needs to 
be uncovered (Blanpain and Fuchs, 2009). For instance, it is unknown whether 
different SC/progenitor reservoirs act autonomously or are interconnected and 
arranged within a certain hierarchy (Jaks et al, 2010). To investigate potential 
functions and epidermal contribution of SC from the HF bulge, we have developed an 
inducible Cre-mouse model enabling us to track the fate of single HFSC-derived 
progeny. From these lineage tracing experiments we have learned that HFSC-
derived progenitors are not only essential for cyclic HF regeneration but also 
continuously reconstitute the SG. During this process of SG renewal, cells exit the HF 
bulge and transit through distinct epidermal progenitor compartments before finally 
repopulating the SG. Thus, our data imply a hierarchy of multipotent keratinocytes 
underlying epidermal homeostasis. Furthermore, tracking HFSC-derived progeny in 
long term studies revealed that the SC pool itself is replenished probably by 
symmetric cell division. Therefore, different signaling cues must exist to instruct 
HFSC to regenerate different integral parts of the epidermis or to replenish the SC 
pool. 
By forcing basal keratinocytes into the sebocyte lineage through manipulation of Lef1 
(Niemann et al., 2002), one of the crucial regulators of fate decision, we could identify 
HFSC as cells of origin for development of ectopic SG. Additionally, new sebocyte 
progenitor compartments are established adjacent to de novo formed SG. 
Intriguingly, fate mapping experiments within an inducible skin tumour model 
(Niemann et al., 2007) clearly demonstrated that HFSC-derived progeny contributes 
to sebaceous tumourigenesis. Finally, manipulation of Lef1 signalling within the 
HFSC niche in a transgenic mouse model results in formation of sebaceous 
adenoma, supporting the hypothesis that HFSC indeed are targeted by 
transformational events during skin tumour development.   
Zusammenfassung 
 93 
6 Zusammenfassung 
Das Hautepithel ist ein komplexes und stark kompartimentiertes Gewebe, bestehend 
aus interfollikulärer Epidermis und assoziierten Anhangsgeweben wie Haarfollikeln 
(HF) und Talgdrüsen (TD) (Cotsarelis, 2006; Fuchs and Horsley, 2008). Um die 
Barriere- und Schutzfunktion der Haut zu gewährleisten, müssen die verschiedenen 
Kompartimente kontinuierlich erneuert werden. Diese spontanen 
Regenerationsprozesse erfordern das Agieren mehrerer Stammzell (SZ)- und 
Progenitorpopulationen (Blanpain and Fuchs, 2009).  
Obwohl Arbeiten der letzten Jahre darauf hindeuten, daß verschiedene 
SZ/Progenitoren im Prozeß der TD-Erneuerung involviert sind (Horsley et al. 2006, 
Jensen et al, 2009, Snippert et al., 2010), ist der zelluläre Mechanismus der TD-
Homeöstase bisher noch ungeklärt. Weiterhin ist nicht untersucht, ob die diversen 
SZ/Progenitorzellreservoirs unabhängig voneinander wirken oder ob sie in ein 
hierarchisches Netzwerk integriert sind (Jaks et al, 2010). Um mögliche Funktionen 
von multipotenten SZ der HF Nische während der Hauthomeöstase zu untersuchen, 
haben wir ein induzierbares Cre-Mausmodell generiert, das uns ermöglicht, einzelne 
HFSZ und ihre Abkömmlinge unter physiologischen Bedingungen im Gewebe zu 
verfolgen. Diese “lineage”-Analysen ergaben, dass HFSZ-Abkömmlinge nicht nur für 
die zyklische Regeneration der HF essentiell sind, sondern auch zur kontinuierlichen 
Erneuerung der TD beitragen. Hierbei verlassen Tochterzellen die HFSZ-Niche und 
durchlaufen distinkte SZ/Progenitorkompartimente, um letztendlich die TD zu 
besiedeln. Unsere Ergebnisse schlagen eine hierarchische Anordnung von multi-
kompetenten Keratinozyten im Prozeß der spontanen epidermalen Erneuerung vor. 
Darüber hinaus hat die Analyse der HFSZ-Niche in Langzeitexperimenten gezeigt, 
daß auch eine Selbsterneuerung des HFSZ-Reservoirs wahrscheinlich mittels 
symmetrischer Zellteilung erfolgt. Die Ergebnisse unterstreichen, dass HFSZ auf 
diverse Signalaktivitäten reagieren müssen, um die verschiedenen Kompartimente 
der Epidermis oder den SZ-Pool zu regenerieren. Durch die epidermis-spezifische 
Manipulation des Transkriptionsfaktors Lef1 werden die Entwicklung von ektopischen 
TD und die Bildung von TD-Tumoren stimuliert (Niemann et al., 2002). Die 
Verfolgung von HFSZ und allen hervorgehenden Tochterzellen innerhalb dieses 
transgenen Mausmodells hat gezeigt, daß HFSZ bzw. ihre Abkömmlinge maßgeblich 
zur Entstehung dieser ektopischen TD beitragen. Einhergehend mit der Entstehung 
neuer TD werden ebenfalls neue Progenitorzellnischen etabliert. “Lineage” Analysen 
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in einem induzierbaren TD-Tumormodell (Niemann et al., 2007) haben gezeigt, dass 
HFSZ-Abkömmlinge an der Entstehung von TD-Tumoren beteiligt sind. Darüber 
hinaus führt die Manipulation der Lef1 Signalgebung in der HFSZ Nische in einem 
neu generierten transgenen Mausmodell ebenfalls zu TD-Tumoren, was für eine 
Transformation von HFSZ als ursächlichen Mechanismus der Tumorigenese spricht.  
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